Document:

EX-4.2

 Exhibit 4.2 

Dated:            18
September            2012 

(1)         The Series B Investors 

(2)         The Series A Investors 

(3)         The Founders 

(4)         The Existing Shareholders 

(5)         The Company 

 
  

Subscription and Shareholders’ Agreement 

relating to 
 Mimecast Limited

 TABLE OF CONTENTS 

 

							
	 1.
	    	 Definitions
	  	 	1	  
	 2.
	    	 Interpretation
	  	 	11	  
	 3.
	    	 Subscriptions
	  	 	12	  
	 4.
	    	 Completion
	  	 	13	  
	 5.
	    	 Warranties
	  	 	14	  
	 6.
	    	 Limitations on warranty claims
	  	 	16	  
	 7.
	    	 Employee share options
	  	 	18	  
	 8.
	    	 The Board
	  	 	18	  
	 9.
	    	 Information rights
	  	 	21	  
	 10.
	    	 Matters requiring consent
	  	 	23	  
	 11.
	    	 Business undertakings
	  	 	24	  
	 12.
	    	 Sale or IPO
	  	 	26	  
	 13.
	    	 Further Issues and transfer of Shares
	  	 	27	  
	 14.
	    	 Restrictive covenants
	  	 	27	  
	 15.
	    	 Confidentiality
	  	 	29	  
	 16.
	    	 Announcements
	  	 	29	  
	 17.
	    	 Costs and expenses
	  	 	30	  
	 18.
	    	 Survival and cessation of obligations of the Founders
	  	 	30	  
	 19.
	    	 Effect of ceasing to hold Shares
	  	 	31	  
	 20.
	    	 Cumulative remedies
	  	 	31	  
	 21.
	    	 Waiver
	  	 	31	  
	 22.
	    	 Termination of Existing Agreements
	  	 	31	  
	 23.
	    	 Entire agreement
	  	 	32	  
	 24.
	    	 Variation
	  	 	32	  
	 25.
	    	 No partnership
	  	 	32	  
	 26.
	    	 Assignment and transfer
	  	 	33	  
	 27.
	    	 Rights of third parties
	  	 	33	  
	 28.
	    	 Conflict between agreements
	  	 	33	  
	 29.
	    	 Counterparts
	  	 	33	  
	 30.
	    	 Notices
	  	 	33	  
	 31.
	    	 Severance
	  	 	34	  
	 32.
	    	 Governing law
	  	 	34	  
	 33.
	    	 Jurisdiction
	  	 	34	  
	 34.
	    	 Confirmation by Founders and Existing Shareholders
	  	 	35	  
	 Schedule 1
	  	 	36	  
		    	 Part 1: The Series B Investors
	  	 	36	  
		    	 Part 2: The Series A Investors
	  	 	36	  
		    	 Part 3: The Founders
	  	 	36	  
		    	 Part 4: The Existing Shareholders
	  	 	37	  
	 Schedule 2
	  	 	38	  
		    	 Part 1: Particulars of the Company
	  	 	38	  
		    	 Part 2: Particulars of the Subsidiaries
	  	 	39	  
	 Schedule 3
	  	 	41	  
		    	 Part 1: Members of the Company - pre-Completion
	  	 	41	  
		    	 Part 2: Members of the Company – post-Completion
	  	 	46	  

  
 2 

							
	 Schedule 4 Conditions to Completion
	  	 	47	  
	 Schedule 5 Completion Warranties
	  	 	48	  
	 Schedule 6
	  	 	61	  
		    	 Part 1: Matters requiring Investor Majority consent
	  	 	61	  
		    	 Part 2: Matters requiring Series A Majority
	  	 	62	  
		    	 Part 3: Matters requiring Series B Majority
	  	 	62	  
		    	 Part 4: Matters requiring Board Consent
	  	 	63	  
		    	 Part 5: Matters requiring Founder Consent
	  	 	64	  
	 Schedule 7 Undertakings
	  	 	66	  
	 Schedule 8 The Properties
	  	 	67	  
	 Schedule 9 Deed of Adherence
	  	 	74	  
	 Schedule 10
	  	 	76	  
		    	 Part 1: Terms of reference for Remuneration Committee
	  	 	76	  
		    	 Part 2: Terms of reference for Audit Committee
	  	 	80	  
	 Schedule 11 Agreed Form Documents
	  	 	84	  
	 APPENDIX Capitalisation Table
	  	 	85	  
	 ATTESTATIONS
	  	 	86	  

  
 3 

					
	DATE:	 	18 September	  	2012

 PARTIES 
  

	(1)	The persons whose names and addresses are set out in Part 1 of Schedule 1 (the “Series B Investors” and each a “Series B Investor”); 

 

	(2)	The persons whose names and addresses are set out in Part 2 of Schedule 1 (the “Series A Investors” and each a “Series A Investor”); 

 

	(3)	The persons whose names and addresses are set out in Part 3 of Schedule 1 (together the “Founders” and each a “Founder”); 

 

	(4)	The persons whose names and addresses are set out in Part 4 of Schedule 1 (the “Existing Shareholders”); and 

  

	(5)	MIMECAST LIMITED (company number 04698693) whose registered office is at 2-8 Balfe Street, London N1 9EG (the “Company”). 

INTRODUCTION 
  

	(A)	The Company is a company limited by shares, brief particulars of which pre-Completion (including prior to the exercise of certain options and the conversion of certain shares) are set out in part 1 of Schedule 2.

  

	(B)	Details of the legal and beneficial ownership of the share capital of the Company is set out in Parts 1 and 2 of Schedule 3. 

  

	(C)	The Series B Investors wish to subscribe for shares in the capital of the Company on and subject to the terms of this Agreement. 

OPERATIVE PROVISIONS 
  

	1.	Definitions 

 In this Agreement, except where a different interpretation is necessary in
the context, the words und expressions set out below shall have the following meanings: 
  

							
	 “Acceptance and Authority”
	  	the form or acceptance and authority relating to the Cash Offer in the agreed form
		
	 “Accounts”
	  	a consolidation of the audited balance sheets and profit and loss accounts of (he Company and the Subsidiaries for the period ended on (he Accounts Date in the agreed form
		
	 “Accounts Date”
	  	31 March 2012
		
	 “Act”
	  	the Companies Act 2006, as amended from time to time

  
 1 

							
	 “Active Founder”
	  	means: (a) Peter Bauer; and (b) Neil Murray, PROVIDED THAT, in each case, if he ceases to be a party to a Relevant Contract, the Board, pursuant to and in accordance with Article 30 of the New Articles, may at any time
thereafter resolve that such Founder is no longer active in the business of any Group Company, whereupon such Founder shall immediately cease to be an Active Founder (in accordance with and subject to the provisions of Article 30 of the New
Articles)
		
	 “Additional Shares”
	  	as defined in clause 3.2
		
	 “A Ordinary Shares”
	  	A ordinary shares of £0.00001 each in the capital of the Company having the rights set out in the New Articles
		
	 “Board”
	  	the board of directors of the Company as constituted from time to time
		
	 “Board Consent”
	  	the consent of the Board, which may be given orally by a majority of the Board (if properly recorded in the minutes at a board meeting) or in writing r Wessing LLP of 5 New Street Square, London EC4A 3TW
		
	 “B Ordinary Shares”
	  	B ordinary shares of £0.00001 each in the capital of the Company having die rights set out in the New Articles
		
	 “Business”
	  	the provision of services to enable unified email management, security, continuity and archiving and any other business engaged in by any Group Company from time to time
		
	 “Business Day”
	  	a day on which the English clearing banks are ordinarily open for the transaction of normal banking business in the City of London (other than a Saturday or Sunday)
		
	 “Cash Offer”
	  	the cash offer document (including the Acceptance and Authority) in the agreed form to be made by the Insight Investors to certain Shareholders
		
	 “CFC”
	  	a controlled foreign corporation, as defined in the Code
		
	 “Claim(s)”
	  	any claim(s) for breach of any Warranty
		
	 “Code”
	  	the Internal Revenue Code of 1966, as amended
		
	 “Company’s Solicitors”
	  	Taylor Wessing LLP of 5 New Street Square, London EC4A 3TW
		
	 “Completion”
	  	completion by the parties of their respective obligations in accordance with clause 4

  
 2 

							
	 “Completion Conditions”
	  	the conditions set out in Schedule 4
		
	 “Completion Date”
	  	the date upon which Completion occurs
		
	 “Confidential Information”
	  	any information or know-how of a secret or confidential nature relating to any Group Company or of any Investor, including (without limitation):
			
		  	(a)	  	any information regarding this Agreement and the investment by the Investors in the Company pursuant to this Agreement or otherwise;
			
		  	(b)	  	any financial information or trading information relating to any Group Company or of any Investor which a party may receive or obtain as a result of entering into this Agreement;
			
		  	(c)	  	in the case of each Group Company, information concerning:
				
		  		  	(i)	  	its finances and financial data, business transactions, dealings and affairs and prospective business transactions;
				
		  		  	(ii)	  	any operational model, its business plans and sales and marketing information, plans and strategies;
				
		  		  	(iii)	  	its customers, including, without limitation, customer lists, customer identities and contact details and customer requirements;
				
		  		  	(iv)	  	any existing and planned product lines, services, price lists and pricing structures (including, without limitation, discounts, special prices or special contract terms offered to or agreed with customers);
				
		  		  	(v)	  	its technology or methodology associated with concepts, products and services including research activities and the techniques and processes used for development of concepts, products and services;
				
		  		  	(vi)	  	its computer systems, source codes and software, including, without limitation, software end technical information necessary for the development, maintenance or operation of
websites;

  
 3 

							
		  		  	(vii)	  	its current Intellectual Property;
				
		  		  	(viii)	  	its directors, officers, employees and shareholders (including, without limitation, salaries, bonuses, commissions and the terms on which such individuals are employed or engaged and decisions or contents of board meetings);
and
				
		  		  	(ix)	  	its suppliers, licensors, licensees, agents, distributors or contractors (“Professional Contacts”) (both current and those who were customers, suppliers, licensors, licensees, agents, distributors or contractors
during the previous two years) including the identity of such Professional Contacts and the terms on which they do business, or participate in any form of commercial co-operation with any Group Company;
			
		  	(d)	  	information concerning or provided to third parties, in respect of which any Group Company owes a duty of confidence (in particular but without limitation, the content of discussions or communications with any
prospective customers or prospective business partner); and
			
		  	(e)	  	any other information which it may reasonably be expected would be regarded by a company as confidential or commercially sensitive.
		
	 “Connected Persons”
	  	as defined in clause 22.2.1
		
	 “C Ordinary Shares”
	  	C ordinary shares of £0.00001 each in the capital of the Company having the rights set out in the New Articles
		
	 “CTA
	  	the Corporation Tax Act 2010
		
	 “Data Protection Legislation”
	  	the Data Protection Acts of 1984 and 1998, and the EU Data Protection Directive 95/46/EC
		
	 “Data Protection Principles”
	  	has the same meaning as the term “Data Protection Principles” under the Data Protection Legislation
		
	 “Dawn Capital Director”
	  	the director (if any) appointed and holding office in accordance with clause 8.3

  
 4 

							
	 “Dawn Capital Director Consent”
	  	the consent of the Dawn Capital Director, which may be given orally (if properly recorded in the minutes at a board meeting) or in writing
		
	 “Dawn Capital Investors”
	  	Dawn Enterprise Capital Fund LP, Dawn Mimecast Holdings Limited and Dawn Mimecast (IT) Holdings Limited and “Dawn Capital Investor” means any one or more of thorn, as the context requires
		
	 “Deed of Adherence”
	  	the deed of adherence substantially in the form set out in Schedule 9
		
	 “Director Indemnification Agreements”
	  	the director indemnification agreements in the agreed form to be entered into between the Company and each of the Insight Director, the Index Director and the Dawn Capital Director
		
	 “Disclosed”
	  	means fairly disclosed to (he Series B Investors in the Disclosure Letter with sufficient explanation and detail to enable the Series B Investors to identify the nature, scope and implications of the matters
disclosed
		
	 “Disclosure Letter”
	  	the letter in the agreed form from the Warrantor to the Series B Investors executed and delivered immediately before Completion
		
	 “Disposal”
	  	means the disposal by the Company of all, or substantially all of its business and assets or the grant of an exclusive license over all or substantially all of the Intellectual Property of the Group
		
	 “Employee Information Table”
	  	the document in the agreed form containing summary information regarding the employees of the Company
		
	 “Encumbrance”
	  	means any mortgage, charge, security interest, hen, pledge, assignment by way of security, equity, claim, right of pre-emption, option, covenant, restriction, reservation, lease, trust, order, decree, judgment, title
defect (including retention of title claim), conflicting claim of ownership or any other encumbrance of any nature whatsoever (whether or not perfected other than liens arising by operation of law)
		
	 “Existing Loan Note Schedule”
	  	means the schedule in the agreed form setting out details of the Existing Loan Notes
		
	 “Existing Loan Notes”
	  	has the meaning given in the New Articles
		
	 “Existing SSA”
	  	means the investment agreement dated 22 December 2009 made between the Company, the Founders, the Investors and the Existing Shareholders (as such terms are defined in such
agreement)

  
 5 

							
	 “Financial Year”
	  	a financial year as determined in accordance with section 390 of the Act
		
	 “Founder Consent”
	  	the consent of each Active Founder, which may be given orally (if properly recorded in the minutes at a board meeting) or in writing
		
	 “Founder Director”
	  	a director appointed in accordance with clause 8.6
		
	 “Founder Shares”
	  	the founder ordinary shares of £0.00001 each in the capital of the Company having the rights set out in the New Articles
		
	 “Fully Diluted Share Capital”
	  	the issued share capital of the Company (assuming that all options and warrants over Shares in the Company and all rights of conversion into Shares in the Company are exercised)
		
	 “Group”
	  	all of the Group Companies
		
	 “Group Companies”
	  	the Company and each and any of the Subsidiaries and “Group Company” means any one of them
		
	 “HMRC”
	  	HM Revenue & Customs
		
	 “ITEPA”
	  	the Income Tax (Earnings and Pensions) Act 2003
		
	 “Index Director”
	  	the director (if any) appointed and holding office in accordance with clause 8.4
		
	 “Index Director Consent”
	  	the consent of the Index Director, which may be given orally (if properly recorded in the minutes at a board meeting) or in writing
		
	 “Index Investors”
	  	means Index Ventures V (Jersey), L.P., Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. and Yucca Partners L.P. Jersey Branch and “Index Investor” means any one or more of them, as the context
requires
		
	 “Insight Director”
	  	the director (if any) appointed and holding office in accordance with clause 8.5
		
	 “Insight Director Consent”
	  	the consent of the Insight Director, which may be given orally (if properly recorded in the minutes at a board meeting) or in writing
		
	 “Insight Investors”
	  	means Insight Venture Partners VII, L.P., Insight Venture

  
 6 

							
		  	Partners (Cayman) VII”, LP, Insight Venture Partners VII (Co-Investors), L.P., Insight Venture Partners (Delaware) VH, L.P. and Insight Venture Partners Co-Investment Fund IL LP. and “Insight
Investor” means any one or more of diem, as the context requires
		
	 “Intellectual Property”
	  	copyrights, trade and service marks, including the Trade Marks, trade names, rights in logos and get-up, inventions, confidential information, trade secrets and know-how, registered designs, design rights, patents,
utility models, semi-conductor topographies, all rights of whatsoever nature in computer software and data, all rights of privacy and all intangible rights and privileges of a nature similar or allied to any of the foregoing, in every case in any
part of the world and whether or not registered; and including all granted registrations and all applications for registration in respect of any of the same
		
	 “Investor Majority”
	  	the consent of the holders of a majority of the Preferred Shores then in issue
		
	 “Investors”
	  	the Series A Investors and the Series B Investors and any other person to whom any of them transfer their shares and who becomes a party to this Agreement as an “Investor” by signing a Deed of Adherence in
accordance with clause 13.2 and is named therein as on “Investor”
		
	 “IPO”
	  	the admission of all or any of the Shares or securities representing those shares (including without limitation American depositary receipts, American depositary shares and/or other instruments) to or the grant of
permission by any like authority for the same to be admitted to or traded or quoted on the NASDAQ Global Market or NASDAQ Global Select Market of the NASDAQ OMX Group Inc., or on the Official List of the United Kingdom Listing Authority or on die
AIM Market operated by the London Stock Exchange Pic or any other recognized investment exchange (as defined in section 285 of the Financial Services and Markets Act 2000)
		
	 “Iron Mountain Contract”
	  	the Email Services Agreement dated April 7, 2009, by and between Mimecast North America, Inc. and Iron Mountain Information Management, Inc (“Iron Mountain”)
		
	 “Key Employee”
	  	any employee who is employed or engaged by the Company:
			
		  	(a)	  	as a director or at management grade; or

  
 7 

							
		  	(b)	  	in a senior capacity with a basic salary of £100,000 per annum or more
		
	 “Lead Index Investor”
	  	Index Ventures V (Jersey), L.P.
		
	 “Listing Rules”
	  	the listing rules made by the United Kingdom Listing Authority as the competent authority pursuant to Part VI of the Financial Services and Markets Act 2000 as amended from time to time and including any guidance or
guidance manual issued by the United Kingdom Listing Authority from time to time relating to or connected with the listing rules
		
	 “Management Accounts”
	  	the management accounts of the Company for the period starting on the Accounts Date and ending on 31 July 2012 in the agreed form
		
	 “Management Rights Letter”
	  	the management rights letter between the Company and die Insight Investors in the agreed form to be entered into at or prior to Completion
		
	 “New Articles”
	  	the new articles of association of the Company in the agreed form to be adopted on or prior to Completion as amended or superseded from time to time
		
	 “New Shares”
	  	the Series B Preferred Shares subscribed by the Series B Investors pursuant to clause 3.1 at a price of US$ 12.067345 per share
		
	 “Ordinary Shares”
	  	the Founder Shares, the A Ordinary Shares, the B Ordinary Shares and the C Ordinary Shares
		
	 “Period”
	  	the period of one year immediately preceding the Relevant Date
		
	 “Permitted Transferee”
	  	has the meaning given in the New Articles
		
	 “Personal Data”
	  	has the same meaning as the term “personal data” under the Data Protection Legislation
		
	 “PFIC”
	  	a passive foreign investment company, as defined in the Code
		
	 “Preferred Shares”
	  	means the Series A Preferred Shares and the Series B Preferred Shares
		
	 “Properties”
	  	the leasehold properties described in Schedule 8
		
	 “Prospective Customer”
	  	any person with whom any Restricted Company is in negotiations or is tendering for the supply of its goods and services

  
 8 

							
	 “Qualifying Fundraising”
	  	means any investors) subscribing for at least £3 million of newly issued share capital in the form of Relevant Securities (as defined in the New Articles) (of a class either currently existing or not yet in
existence) in a single transaction or a series of related transactions
		
	 “Registration Rights Agreement”
	  	the registration rights agreement in the agreed form to be entered into between the Company and each of the Investors
		
	 “Relevant Contract’
	  	means an employment contract or consulting agreement between a Founder and any Group Company, the terms of which require such Founder to work for such Group Company for at least an aggregate of four days per calendar
month
		
	 “Relevant Date”
	  	means, in respect of a Founder, the earlier of the Termination Date and the date on which such Founder commenced any period of garden leave pursuant to clause 13.2 of his Service Agreement
		
	 “Resolutions”
	  	the resolutions in agreed form to be passed by die Company by written resolution as specified in paragraph (a) of Schedule 4
		
	 “Restricted Area”
	  	means the United Kingdom, the United States of America, the Republic of South Africa and each country within the European Union in respect of which (i) any Restricted Company has or is planning to have material business
operations as at the Termination Date or (ii) the relevant Founder has direct or indirect responsibility or has received Confidential Information during the Period
		
	 “Restricted Company”
	  	any Group Company with which the relevant Founder shall have “been engaged or involved or about which he received Confidential Information at any time during the Period:
		
	 “Sale”
	  	a Share Sale or a Disposal, both as defined in the New Articles
		
	 “Sale and Purchase Deeds”
	  	the sale and purchase deeds to be entered into between (amongst others) the Insight Investors and certain Shareholders
		
	 “Securities Act”
	  	the United States Securities Act of 1933, as amended
		
	 “Senior Employee”
	  	any employee who is as at the Termination Date employed or engaged by the Company

  
 9 

							
		  	(a)	  	as a director or at management grade; or
			
		  	(b)	  	in a senior capacity with a basic salary of £150,000 per annum or more
		
	 “Series A Majority”
	  	the consent of the holders of a majority of the Series A Preferred Shares then in issue
		
	 “Series A Preferred Shares”
	  	Series A Preferred Shares of £0.00001 each in the capital of the Company having the rights set out in the New Articles
		
	 “Series B Majority”
	  	the consent of the holders of a majority of the Series B Preferred Shares then in issue
		
	 “Series B Preferred Shares”
	  	Series B Preferred Shares of £0.00001 each in the capital of the Company having the rights set out in the New Articles
		
	 “Series B Investors’ Solicitors”
	  	Goodwin Procter LLP of The New York Times Building, 620 Eighth Avenue, New York, New York 10018, USA
		
	 “Service Agreements”
	  	the agreements entered into between the Company and each of the Founders on or about 22 December 2009
		
	 “Shareholders”
	  	each of the Founders, the Existing Shareholders and the Investors and the other members of the Company from time to time who are a party to this Agreement
		
	 “Share Option Plan”
	  	means the Company’s 2007 Key Employee Share Option Scheme and the 2010 Key Employee Share Option Scheme
		
	 “Shares”
	  	means the Ordinary Shares and the Preferred Shares
			
	 “Social Obligations”
	  	 (a)
	  	any common or statutory law, regulation, directive, code of practice or other law in each case having force of law in any jurisdiction relating to the relationship between, the Company and its employees, any potential
employee and any trade unions and/or the health and safety of its employees;
			
		  	 (b)
	  	and any agreements or legally binding arrangements between the Company and its employees and/or any trade union or other organization which represents some or all of its employees
		
	 “Subsidiary”
	  	means a subsidiary of the Company as defined in section 1159 of the Act, brief particulars of which are set out in Part 2 of Schedule 2

  
 10 

							
	 “Taxation”
	  	all forms of taxation, duties, rates, levies, contributions, withholdings, deductions, liabilities to account, charges and imposts whether imposed in the United Kingdom or elsewhere in the world
		
	 “Taxing Authority”
	  	HMRC and any other governmental, state, federal, provincial, local governmental or municipal authority, body or official whether of the United Kingdom or elsewhere in the world
		
	 “Termination Date”
	  	the date upon which the Founder concerned ceases to be a director or employee of, or a consultant to, a Group Company whichever is the latest
		
	 “Trade Marks”
	  	the trade and service marks and applications, together with associated logos, owned by any Group Company, details of which are set out in die Disclosure Letter
		
	 “Transfer Notice”
	  	shall have the meaning given to it in the New Articles
		
	 “Warranties”
	  	the warranties given pursuant to clause 5 (references to a particular warranty being to a statement set out in Schedule 5)
		
	 “Warrantor”
	  	the Company

  

	2.	Interpretation 

  

	2.1	Words and expressions which arc defined in the New Articles shall have the meanings attributed to them therein when used in this Agreement unless otherwise defined or the context otherwise requires. 

 

	2.2	Words and expressions which are defined in the Act shall have the meanings attributed to them therein when used in this Agreement unless otherwise defined or the context otherwise requires. 

 

	2.3	The clause and paragraph headings and the table of contents used in this Agreement are inserted for ease of reference only and shall not affect construction. 

 

	2.4	References to persons shall include bodies corporate, unincorporated associations and partnerships, in each case whether or not having a separate legal personality. 

 

	2.5	References to documents “in the agreed form” are to documents in terms agreed on behalf of the Company and the Series B Investors and initialed on behalf of each such party for the purposes of identification
only. 

  

	2.6	References to those of the parties that are individuals include their respective legal personal representatives. 

  
 11 

	2.7	References to “writing” or “written” includes any other non-transitory form of visible reproduction of words, 

  

	2.8	References to the word “include” or “Including” (or any similar term) are not to be continued as implying any limitation and general words introduced by the word “other” (or any similar
term) shall not be given a restrictive meaning by reason of the fact that they are preceded or followed by words indicating a particular class of acts, matters or things. 

 

	2.9	Except where the context specifically requires otherwise, words importing one gender shall be treated as importing any gender, words importing individuals shall be treated as importing corporations and vice versa, words
importing the singular shall be treated as importing the plural and vice versa, and words importing the whole shall be treated as including a reference to any part thereof, 

 

	2.10	References to statutory provisions, enactments or EC Directives shall include references to any amendment, modification, extension, consolidation, replacement or re-enactment of any such provision, enactment or EC
Directive (whether before or after the date of this Agreement), to any previous enactment which has been replaced or amended and to any regulation, instrument or order or other subordinate legislation made under such provision, enactment or EC
Directive unless any such change imposes upon any party any liabilities or obligations which arc more onerous than as at the date of this Agreement. 

  

	2.11	Section 1122 of the CTA shall apply to determine whether one person is connected with another for the purposes of this Agreement. 

 

	2.12	References in clauses 5 (warranties), S (the board), 9 (Information rights), 11 (business undertakings), 14 (restrictive covenants), 15 (confidentiality), Schedule 5 (warranties) and Part 4 of Schedule 6 (board consent
matters) to the Company and the Board shall include each of the subsidiaries of the Company and the directors for the time being of those subsidiaries respectively. 

 

	3.	Subscriptions 

  

	3.1	Subject to the provisions of clause 4, the Series B investors apply for the allotment and issue to them at Completion of the following shares as set out in the table below and the Company accepts such applications:

  

									
	 Series B Investors
	  	No. of Series B Preferred
Shares	 	  	Total subscription
monies (USS)	 
	 Insight Venture Partners VTLLJ.
	  	 	1,290,384	  	  	 	15,571,500	  
	 Insight Venture Partners (Cayman) YD, LP.
	  	 	568,054	  	  	 	6,854,900	  
	 Insight Venture Partners VII (Co-Investors), LP.
	  	 	29,867	  	  	 	360,415	  
	 Insight Venture Partners (Delaware) VII, L.P.
	  	 	81,620	  	  	 	984,936	  
	 Insight Venture Partners Coinvestment Fund IL LP,
	  	 	1,344,806	  	  	 	16,228,249	  
		  	  
	  
	 	  	  
	  
	 
	 TOTAL
	  	 	3,314,731	  	  	 	40,000,000	  
		  	  
	  
	 	  	  
	  
	 

  
 12 

	3.2	Each of the parties (other than the Company) agrees to vote in favour of the Resolutions and hereby irrevocably waives or procures the waiver of all or any pre-emption rights he or his nominees may have pursuant to the
Company’s articles of association or otherwise so as to enable the issue of any shares in the capital of die Company contemplated by this Agreement to proceed free of any such pre-emption rights. 

 

	4.	Completion 

  

	4.1	Subject to the Completion Conditions being satisfied or waived by the Series B Investors on or prior to Completion, Completion of the subscription by the Series B Investors of the New Shares shall take place at the
offices of the Series B Investors’ Solicitors or by electronic exchange of pdf signatures on the Completion Date (or at such other place as the Company and the Series B Investors shall agree) when the events set out in clause 4.2 shall take
place in such order as the Series B Investors may require. 

  

	4.2	The following events shall occur on the Completion Date: 

  

	 	(a)	each Series B Investor shall (subject to clause 17) pay the sum set out against its name in column 3 of the table in clause 3.1 above (being the aggregate subscription price for the New Shares subscribed by the relevant
Series B Investor) by electronic funds transfer to the bank account of the Company’s Solicitors as set out below and payment made in accordance with this clause 4.2 shall constitute a good discharge for the relevant Series B Investor of its
obligations under this clause 4.2: 

  

					
	Account name	  	:	  	Taylor Wessing USS Client Account
	Bank	  	:	  	National Westminster Bank
	Account Number	  	:	  	08498342
	Sort Code	  	:	  	60-80-08
	Bank Address	  	:	  	Law Courts, Temple Bar Branch, PO Box 10720,217 Strand, London WC2R IAL
	IBAN	  	:	  	GB07NWBK60730108498342
	SWIFT/BIC	  	:	  	NWBKGB2L

  
 13 

	 	(b)	a meeting of the Board shall be held at which the Company shall: 

  

	 	(i)	subject to receipt of the relevant subscription amount, issue the New Shares credited as fully paid to the Series B Investors and enter their names in the register of members in respect thereof; 

 

	 	(ii)	subject to receipt of the relevant subscription amount, execute and deliver to die Series B Investors certificates for the New Shares; 

 

	 	(iii)	appoint Jeff Lieberman as the Insight Director; 

  

	 	(iv)	approve and authorise the execution by the Company of the Registration Rights Agreement; 

  

	 	(v)	approve and authorise the execution by the Company of the Director Indemnification Agreements; and (vi) pass any such other resolutions as may be required to carry out the obligations of the Company under this
Agreement; 

  

	 	(c)	the Company and the Investors and the Founders shall enter into the Registration Rights Agreement; 

  

	 	(d)	the Company and each of the Insight Director, the Index Director and the Dawn Capital Director shall enter into the Director indemnification Agreements; and 

 

	 	(e)	the Insight Investors and certain Shareholders and Dawn Mimecast (IV) Holdings Limited and certain Shareholders shall enter into Sale and Purchase Deeds. 

 

	4.3	As soon as reasonably practicable following Completion (and in any event within 5 Business Days of Completion)) the Company shall dispatch the Cash Offer (including the Acceptance and Authority) on behalf of the Insight
Investors. 

  

	5.	Warranties 

  

	5.1	The Warrantor acknowledges that the Series B Investors have been induced to enter into this Agreement and to subscribe for the New Shares on the basis of and in reliance upon the Warranties amongst other things.

  

	5.2	The Warrantor warrants to the Series B Investors that each and every Warranty set out in Schedule 5 is true and accurate at the date of this Agreement subject only to: 

 

	 	(a)	the matters Disclosed in die Disclosure Letter; and 

  

	 	(b)	any exceptions expressly provided for under this Agreement. 

  

	5.3	Each Warranty is a separate and independent warranty, and, save as otherwise expressly provided, no Warranty shall be limited by reference to any other Warranty or by me other terms of this Agreement and the Disclosure
Letter. 

  
 14 

	5.4	The rights and remedies of the Series B Investors in respect of any breach of any of the Warranties shall not be affected by Completion, any investigation made by or on behalf of the Series B Investors into the affairs
of the Company or any other event or matter whatsoever which otherwise might have affected such rights and remedies except a specific and duly authorised written waiver or release. 

 

	5.5	No information relating to the Company of which the Series B Investors have knowledge (actual or constructive) other than by reason of it being disclosed in accordance with clause 5.2(a) shall prejudice any Claim which
the Sales B Investors shall be entitled to bring or shall operate to reduce any amount recoverable by the Series B Investors under this Agreement, 

  

	5.6	Where any Warranty is qualified by the expression “so far as the Warrantor is aware” or words having similar effect, such Warranty shall be deemed to include a statement that such awareness means both the
actual knowledge of the Company and also such knowledge which the Company would have had if it had made duo and careful enquiry of Peter Bauer, Neil Murray, Peter Campbell, Alan Kenny, Garth Wittles and Mark Bilbe to ascertain whether each Warranty
is correct and not misleading. 

  

	5.7	The Series B Investors agree among themselves that the following provisions shall (unless they subsequently agree amongst themselves to the contrary acting by way of a Series B Majority) apply in relation to the
enforcement of any of the obligations of the Warrantor owed to the Series B Investors under this Agreement (the “Obligations”): 

  

	 	(a)	no claim in respect of any breach of the Obligations shall be brought by any of the Series B Investors without the prior written consent of a Series B Majority provided that all Series B Investors have been informed of
the breach of the Obligations and consulted prior to a Series B Majority decision being made; 

  

	 	(b)	tire costs incurred by any Series B Investors in bringing a claim in respect of any breach of the Obligations shall be borne by all of the Series B Investors proportionately to their holding of New Shares at that time;
and 

  

	 	(c)	any damages obtained as a result of any claim in respect of any breach of the Obligations will, after deduction of all costs and expenses, be divided amongst the Series B Investors proportionately to their holding of
Now Shares as a percentage of all New Shares at that time. 

 Any Series B Investor shall be entitled to waive the Obligations
owed to it at any time prior to the issue of proceedings with the consequence that it shall not be liable to hear its proportion of the costs referred to in (b) above (which costs per Series B Investor shall increase rateably for the remaining
Series B Investors) nor entitled to any of the damages referred to in (c) above. 
  

	5.8	The Company acknowledges and agrees that, in connection with any Claim by the Series B Investors for breach of the Obligations, the Series B Investors shall be entitled to seek, as part of any Claim for damages, an
amount equal to the Series B Investors’ proportionate share of the amount actually paid by the Company to the Series B Investor as a result of any such Claim. 

  
 15 

	6.	Limitations on warranty claims 

  

	6.1	The limitations set out in this clause 6 shall not apply to the Warrantor in respect of any Claim which is: 

  

	 	(a)	the consequence of fraud, dishonesty, wilful concealment or wilful misrepresentation by or on behalf of the Warrantor, or 

  

	 	(b)	which is a result of a breach of warranty statement 1 (share capital) of Schedule 5. 

  

	6.2	No Claim may be made against the Warrantor unless written notice of such Claim is served on the Warrantor giving reasonable details of the Claim as soon as reasonably practicable after the Series B Investors become
aware of any fact or matter which entitles them to bring a Claim and, in any event, by no later than die date which is the later of three months after delivery to the Series B Investors of the Board approved audited accounts of the Company for the
Financial Year of the Company ending 2013 and the second anniversary of the date of this Agreement. Failure to give reasonable details of any Claims shall not prevent the Series B Investors from proceeding with any Claim otherwise made properly
under this Agreement. 

  

	6.3	The aggregate liability of the Warrantor in respect of all and any Claims shall be limited to an amount equal to die aggregate amount subscribed for New Shares by the Series B Investors pursuant to this Agreement,
together with the proper and reasonable costs of recovery in respect of any Claim incurred by or on behalf of the Series B Investors; 

  

	6.4	The Warrantor shall not be liable in respect of any Claim unless the aggregate liability for all Claims exceeds £500,000, in which case the Warrantor shall be liable for the entire amount and not merely the
excess. 

  

	6.5	In calculating liability for Claims for the purposes of clause 6.4 above, any Claim which is less than £10,000 (excluding interest, costs and expenses) shall be disregarded. For these purposes, a number of Claims
arising out of the same or similar subject matter, facts, events or circumstances shall be aggregated and form a single Claim. 

  

	6.6	No liability of the Warrantor in respect of any breach of any Warranty shall arise: 

  

	 	(a)	if such breach occurs by reason of any matter which would not have arisen but for the coming into force of any legislation not in force at the Completion Date or by reason of any change to Taxation Authority practice or
extra-statutory concession occurring after the Completion Date; 

  

	 	(b)	to the extent that specific allowance, provision or reserve has been made in the Accounts or in the Management Accounts specifically in respect of the matter to which such liability relates; 

  
 16 

	 	(c)	to the extent that such breach or claim arises as a result of any change in the accounting bases or policies in accordance with which the Company values its assets or calculates its liabilities or any other change in
accounting practice from the treatment or application of the same used in preparing the Accounts (save to the extent that such changes are required to correct errors or because relevant generally accepted accounting principles have not been complied
with); 

  

	 	(d)	to the extent that die Company is entitled to claim an indemnity against the loss or damage suffered which is the object of the Claim under the terms of any insurance policy for the time being in force and the loss and
damage has actually been recovered by the Company under such insurance policy, except to the extent that the insurance premium payable for such insurance policy (or the renewal thereof) is thereby increased; 

 

	 	(e)	to the extent that no Claim would have arisen (or the amount of any Claim would not have increased) but for a transaction or arrangement entered into after the Completion Date with the written consent of the Investor
Majority. 

  

	6.7	The Series B Investors shall be entitled to make a Claim in respect of liability which is contingent or unascertained provided that written notice of the Claim (giving as far as practical the amount and details of the
Claim) is given to the Warrantor before the expiry of the period specified in clause 6.2. 

  

	6.8	The Warrantor shall not be liable for any Claim if the alleged breach which is the subject of the Claim is capable of remedy and is remedied to the reasonable satisfaction of the Series B Investors within 60 Business
Days of the dale on which the notice in clause 6.2 above is received by the Warrantor. 

  

	6.9	Nothing in this Agreement shall prejudice each Series B Investors duty under common law to mitigate any loss or liability which is the subject of a Claim. 

 

	6.10	The liability of the Warrantor for any Claim notified under clause 6.2 shall (if it has not been previously satisfied, settled or withdrawn) cease 6 months after the date on which the Claim was notified (or in the case
of a claim under clause 6.7, 6 months after the contingent or unascertained liability ceases to be contingent or unascertained) unless court proceedings have been started in respect of it or it has been submitted to arbitration and the proceedings
or submission to arbitration has not been withdrawn or terminated; provided, however, that any unelapsed part of the six (6) month period shall be tolled while the parties are actively seeking to resolve such Claim and/or are engaged in
settlement negotiations or discussions with respect to such Claim. 

  

	6.11	Subject to clause 6.6(d), the liability of the Warrantor for a Claim shall be reduced if any Group Company actually receives any recoveries from any third party (including a Taxing Authority or insurer) in respect of
the loss suffered by a Group Company giving rise to the Claim and the proportion by which such liability shall reduce shall be the proportion that the amount recovered (less the Group Company’s reasonable costs and expenses of recovery and any
amount in respect of Taxation payable in respect of the amount recovered) bears to the loss suffered by the Group Company. 

  
 17 

	6.12	If, subsequent to any payment to any of the Series B Investors in respect of any Claim, any Group Company actually receives any payment from any third party directly in respect of the loss suffered by a Group Company
which resulted in the Claim, the relevant Series B Investors shall, except to the extent that any direct or indirect loss of the Series B Investors has not been compensated or would, following such reimbursement, not be compensated, reimburse to the
Warrantor an amount equal to the proportion of such Series B Investors bears to such loss (less the Series B Investors’ and the Group Company’s reasonable costs and expenses of recovery and any amount in respect of Taxation payable in
respect of the amount recovered). 

  

	6.13	claim for breach of any of the Warranties shall be brought after an IPO. 

  

	7.	Employee share options 

 Save with Founder Consent, the consent of a Series A Majority
and a Series B Majority, the Company shall not issue options to directors, employees and consultants of any Group Company save for options in respect of a maximum of 915,613 B Ordinary Shares (including all option giants currently pending) pursuant
to the Share Option Plan, the recipients and the terms of all such option grants to be approved by the Board. 
  

	8.	The Board 

  

	8.1	The members of the Board immediately following Completion shall be the Founders, the Insight Director, the Index Director, the Dawn Capital Director, Peter Campbell and two independent non-executive directors (namely
Christopher FitzGerald and Michael Hedger). Board meetings will be held at intervals of not more than ten (10) weeks and at least six (6) Board meetings will be held in each calendar year, at least four (4) of which will be held in
person (meaning at least a quorum of Directors are physically present in the same location). 

  

	8.2	Save with Insight Director Consent, Index Director Consent and Founder Consent, no business shall be transacted at any meeting of the Board (or committee of the Board) save for that specified in the agenda referred to
in clause 8.9. 

  

	8.3	For so long as a Dawn Capital Investor is a Shareholder, the Dawn Capital Investors shall have the right jointly: 

  

	 	8.3.1	to appoint and maintain in office such natural person as the Dawn Capital Investors may jointly from time to time nominate as a director of the Company (and as a member of each and any committee of the Board) and to
remove any director so appointed and, upon his removal whether jointly by die Dawn Capital Investors or otherwise, jointly to appoint another director in his place; or 

 

	 	8.3.2	to appoint a representative to attend as an observer at each and any meeting of the Board and of each and any committee of the Board who will be entitled to speak at any such meetings but will have no vote and no
authority to bind the Company in any way. 

  
 18 

 Norman Fiore shall be deemed to be the first director appointed pursuant to this clause 8.3. 

 

	8.4	For so long as an Index Investor is a Shareholder, the Lead Index Investor shall have the right: 

  

	 	(a)	to appoint and maintain in office such natural person as the Index Investors may from time to time nominate as a director of the Company (and as a member of each and any committee of the Board) and to remove any
director so appointed and, upon his removal whether by the Index Investors or otherwise, to appoint another director in his place; or 

  

	 	(b)	to appoint a representative to attend as an observer at each and any meeting of the Board and of each and any committee of the Board who will be entitled to speak at any such meetings but will have no vote and no
authority to bind the Company in any way. 

 Bernard Dallé shall be deemed to be the first director appointed pursuant
to this clause 8.4. 
  

	8.5	For so long as an Insight Investor is a Shareholder, the Insight Investors shall have the right jointly (in their discretion) to either. 

 

	 	(a)	appoint and maintain in office such natural person as the Insight Investors may from time to time nominate as a director of the Company (and as a member of each and any committee of the Board) and to remove any director
so appointed and, upon his removal whether by the Insight Investors or otherwise, to appoint another director in his place; or 

  

	 	(b)	appoint a representative to attend as an observer at each and any meeting of the Board and of each and any committee of the Board who will be entitled to speak at any such meetings but will have no vote and no authority
to bind the Company in any way. 

 Jeff Lieborman shall be deemed to be the first director appointed pursuant to this clause
8.5. 
  

	8.6	The Founders shall each have the right 

  

	 	8.6.1	to appoint and maintain in office such natural person as such Founder may from time to time nominate as a director of the Company and to remove any director so appointed and, upon Ids removal whether by his appointing
Founder or otherwise, to appoint another director in his place; or 

  
 19 

	 	8.6.2	to appoint a representative to attend as an observer at each and any meeting of the Board and of each and any committee of the Board (provided that the relevant Founder may be precluded from the relevant part of any
committee meeting where who has a Conflict (as defined in Article 8.1 of the New Articles) or who is otherwise, whether directly or indirectly, interested in an existing or proposed transaction or arrangement with the Company which is the subject of
the discussion) who will be entitled to speak at any such meetings but will have no vote and no authority to bind the Company in any way. 

The Founders shall be deemed to be the directors appointed hi accordance with this clause 8.6 at Completion. 

 

	8.7	Appointment and removal of the Dawn Capital Director, the Index Director, the Insight Director and a Founder Director shall be by written notice to the Company winch shall take effect on delivery at its registered
office or at any meeting of the Board or committee thereof. 

  

	8.8	The independent non-executive directors on the Board shall be appointed by the Board from time to time. Immediately following Completion these shall be Michael Hedger (who shall also be chairman) and Christopher
FitzGerald. Any new independent director appointed shall be nominated by agreement of the Insight Investors, the Index Investors and the Founders and appointed subject to the Board’s approval of his or her appointment. Peter Campbell shall be
the initial company secretary of the Company following Completion. 

  

	8.9	The Company shall send to each of the Dawn Capital Director, the Index Director, the Insight Director and the Founder Directors (if any) (or any observer appointed by the Index Investors, the Dawn Capital Investors, the
Insight Investors or the Founders) (in electronic form if so required): 

  

	 	(a)	reasonable advance notice of each meeting of the Board (being not fewer than five Business Days) and each committee of the Board, such notice to be accompanied by a written agenda specifying the business to be discussed
at such meeting together with all relevant papers; and 

  

	 	(b)	as soon as reasonably practicable after each meeting of the Board (or committee of the Board) (and in any event within 28 days of such meeting) a copy of the minutes. 

 

	8.10	Each of the Dawn Capital Director, the Index Director, the Insight Director and the Founder Directors shall be entitled to make ad-hoc requests to the chairman of the Board for an observer to attend any meeting of the
Board, such decision shah be made in the chairman’s absolute discretion. 

  

	8.11	The Company will: 

  

	 	8.11.1	pay an annual fee of £12,000 (plus VAT) to the Dawn Capital Director (if any); and 

  
 20 

	 	8.11.2	reimburse the Dawn Capital Director, the Index Director, the Insight Director, the Founder Directors and any observer appointed by the Index Investors, the Dawn Capital Investors, the Insight Investors or the Founders
with the reasonable costs and out of pocket expenses incurred by them in respect of attending meetings of the Company or carrying out authorised business on behalf of the Company. 

 

	8.12	A remuneration committee and an audit committee, in each case having the terms of reference and membership set out in Parts 1 and 2 respectively of Schedule 10 and otherwise, satisfactory to the Board shall be
maintained by the Board. 

  

	9.	Information rights 

  

	9.1	The Company shall for each month prepare management accounts (in a form approved by the Board from time to time) with comparisons to budgets and containing trading and profit and loss accounts, balance sheets, cash flow
statements and forecasts and shall deliver them to the Investors and the Founders within 21 days after (he end of each month. The first management accounts shall be delivered to the Investors and the Founders within 21 days after the end of the
month in which Completion takes place. 

  

	9.2	The Company shall at least 14 days prior to the end of each financial year prepare and deliver to each Investor and each Founder a detailed operating and capital budget and cash flow forecast in respect of the next
financial year in such form as approved by the Board from time to time. 

  

	9.3	The audited accounts of the Company and audited consolidated accounts of the Group Companies in respect of each accounting period together with the relative audit and management letters and all correspondence between
the Company and the auditors of the Company concerning the accounts, shall be completed and approved by the Board and delivered to the Investors and the Founders within six months after the end of the accounting period to which such audited accounts
relate. 

  

	9.4	The Company shall prepare a schedule of the Company’s issued share capital and any warrants and/or options to acquire shares and/or convertible securities, broken down by shareholder, optionholder, warrant holder
and convertible securities holder (as appropriate) and including the percentage of the Fully Diluted Share Capital held by each holder and shall deliver such share capital schedule to the Investors and the Founders within 21 days after the end of
each six month period in the Company’s financial year. 

  

	9.5	The Company shall provide die Investors and the Founders as soon as reasonably practicable with such other information concerning the Company and its business as the Investors and/or the Founders may reasonably require
from time to time. 

  

	9.6	 If the Company does not comply with its obligations in clauses 9.1 to 9.5, the Insight Investors, the Insight Director, the Index Investors, the Index
Director and a firm of accountants nominated by the Insight Investors and the Index Investors at the Company’s expense will be entitled to attend the Company’s premises to examine the books and accounts of die Company and to discuss the
Company’s affairs, finances and accounts with its directors, officers and senior employees. Each Founder and the Company 

  
 21 

	 	
separately undertakes to the Insight Investors and the Index Investors to co-operate with any accountants or representatives appointed by them pursuant to this clause 9.6. The Insight Investors
and the Index Investors shall notify the Dawn Capital Director and the Founders in writing of any appointment of accountants for this purpose and the date of any inspection to be made and shall provide copies of the same information and
documentation collected by any accountant and/or representative for the Insight Investors and the Index Investors to the Dawn Capital Director and the Founders. 

  

	9.7	The Dawn Capital Director and any observer appointed by the Dawn Capital Investors shall be at liberty from time to time to make full disclosure to the Dawn Capital Investors of any information relating to the Company.

  

	9.8	The Index Director and any observer appointed by the Index Investors shall be at liberty from time to time to make full disclosure to the Index Investors of any information relating to the Company. 

 

	9.9	The Insight Director and any observer appointed by the Insight Investors shall be at liberty from time to time to make full disclosure to the Insight Investors of any information relating to the Company.

  

	9.10	The Founder Directors and any observers appointed by the Founders shall be at liberty from time to time to make full disclosure to the Founders of any information relating to the Company. 

 

	9.11	Each Investor shall be at liberty from time to time to make such disclosure: 

  

	 	(a)	to its partners, trustees, shareholders, unitholders and other participants and/or to any Member of the same Group or Member of the Same Fund Group (each as defined in the New Articles) for die purposes of, but not
limited to, reviewing existing investments and investment proposals; 

  

	 	(b)	to any lender to the Company and/or to any shareholder of the Company, 

  

	 	(c)	about the Company as shall be required by law and any regulatory authority to which any Investor is subject; and 

  

	 	(d)	to me Company’s auditors and/or any other professional advisers of the Company, in relation to the business affairs and financial position of the Company as it may in its reasonable discretion think fit.

  

	9.12	Other than any information which is required to be made available to shareholders of a company, the right of a Founder to receive information referred to in this clause 9 shall terminate for so long as the Board (acting
reasonably and having given written notice to the Founder of such opinion) believes that the relevant Founder is concerned, engaged or interested directly or indirectly in any capacity whatsoever in any business or entity competing with the business
carried on by any Group Company. 

  
 22 

	10.	Matters requiring consent 

  

	10.1	Each of the Shareholders who are a party to this Agreement shall exercise all voting rights and powers of control available to him in relation to the Company to procure that: 

 

	 	(a)	for so long as any Preferred Shares are in issue, save with the prior written consent of an Investor Majority, the Company shall not effect any of the matters referred to in Part 1 of Schedule 6; 

 

	 	(b)	for so long as any Series A Preferred Shares are in issue, save with the prior written consent of a Series A Majority, the Company shall not effect any of the matters referred to in Part 2 of Schedule 6;

  

	 	(c)	for so long as any Series B Preferred Shares are in issue, save with the prior written consent of a Series B Majority, the Company shall not effect any of the matters referred to in Part 3 of Schedule 6;

  

	 	(d)	save with Board Consent, no Group Company shall effect any of the matters referred to in Part 4 of Schedule 6; and save with Insight Director Consent, Index Director Consent and Founder Consent, no Group Company snail
affect any of the matters referred to in paragraph (e) of Part 4 of Schedule 6; 

  

	 	(e)	save with Founder Consent, the Company shall not effect any of the matters referred to in Part 5 of Schedule 6; and 

  

	 	(f)	save with Dawn Capital Director Consent, amend the New Articles where such amendments shall adversely affect die rights attached to the Series A Preferred Shares and/or the A Ordinary Shares held by the Dawn Capital
Investors (and/or any Permitted Transferee of any Dawn Capital Investor to whom a Dawn Capital Investor has transferred Shares) whether directly or indirectly, save as part of a Qualifying Fundraising after first consulting with the Dawn Capital
Director on any proposed changes. 

  

	10.2	As a separate obligation, severable from the obligations in clause 10.1, the Company agrees that 

  

	 	(a)	for so long as any Preferred Shares are in issue, save with the prior written consent of an Investor Majority, the Company shall not effect any of the matters referred to in Part 1 of Schedule 6; 

 

	 	(b)	for so long as any Series A Preferred Shares are in issue, save with the prior written consent of a Series A Majority, the Company shall not effect any of the matters referred to in Part 2 of Schedule 6;

  

	 	(c)	for so long as any Series B Preferred Shares are in issue, save with the prior written consent of a Series B Majority, the Company shall not effect any of the matters referred to in Part 3 of Schedule 6;

  
 23 

	 	(d)	save with Board Consent, no Group Company shall effect any of the matters referred to in Part 4 of Schedule 6; and save with Insight Director Consent, Index Director Consent and Founder Consent, no Group Company shall
effect any of the matters referred to in paragraph (e) of Part 4 of Schedule 6; 

  

	 	(e)	save with Founder Consent, the Company shall not effect any of the matters referred to in Part 5 of Schedule 6; and 

  

	 	(f)	save with Dawn Capital Director Consent, amend the New Articles where such amendments shall adversely affect the rights attached to the Series A Preferred Shares and/or the A Ordinary Shares held by the Dawn Capital
Investors (and/or any Permitted Transferee of any Dawn Capital Investor to whom a Dawn Capital Investor has transferred Shares) whether directly or indirectly, save as part of a Qualifying Fundraising after first consulting with the Dawn Capital
Director on any proposed changes. 

  

	10.3	The Index Director or such other person as the Index Investors shall nominate in writing to the Board shall be authorised to communicate in writing the consent of the Index Investors to any of the matters referred to in
Part 1 of 10.3 Schedule 6 and/or Part 2 of Schedule 6 and/or paragraph (e) of Part 4 of Schedule 6. 

  

	10.4	The Insight Director or such other person as the Insight Investors shall nominate in writing to the Board shall be authorised to communicate in writing the consent of the Insight Investors to any of the matters referred
to in Part I of Schedule 6 and/or Part 3 of Schedule 6 and/or paragraph (e) of Part 4 of Schedule 6. 

  

	10.5	The Dawn Capital Investors (or any of them) or such other person as the Dawn Capital Investors may nominate in writing to the Board shall be authorised to communicate in writing Dawn Capital Director Consent to any of
the matters referred to in clauses 10.1(f) or 10.2(f). 

  

	10.6	Any Active Founder or such other person as any Active Founder shall nominate in writing to the Board shall be authorised to communicate Founder Consent on behalf of the relevant Active Founder to any of the matters
referred to in Part 5 of Schedule 6 and/or paragraph (e) of Part 4 of Schedule 6. 

  

	10.7	For the avoidance of doubt, no consent right set out in this clause 10 shall be asserted by any party in connection with the exercise of any specific right or power of any holder of Shares specifically negotiated and
expressly set out in this Agreement, the New Articles or the Registration Rights Agreement. 

  

	11.	Business undertakings 

  

	11.1	The Founders severally undertake, so far as it lies within their respective power to do so, to use their reasonable endeavors to promote the best interests of the Company and so far as it lies within their respective
power shall ensure that Ore Business is conducted with good business practice. 

  
 24 

	11.2	Unless otherwise agreed by an Investor Majority and Founder Consent and Dawn Capital Director Consent and the Series B Majority, the Company shall apply the proceeds of the subscription by the Series B Investors for the
New Shares in the furtherance of the Business in accordance with the budgets adopted pursuant to clause 9.2 on the terms of this Agreement. 

  

	11.3	The Founders and the Company severally undertake to the Investors to procure, so far as it lies within their respective power to do so, that the Founders and the Company and, where applicable, each Group Company will
comply with the requirements set out in Schedule 7. 

  

	11.4	Within six (6) months following the Completion. Date, the Company shall document and implement a complete transfer pricing with respect to all significant transactions among the Group Companies. 

 

	11.5	The Company agrees to use its commercially reasonable efforts to refinance the Existing Loan Notes on terms reasonably satisfactory to the Board (including the Insight Director) as soon as reasonably practicable
following the Completion Date. 

  

	11.6	No later than, three (3) months following the end of the Company’s taxable year, the Company shall provide the following information to each Investor (i) the Company’s capitalization table as of the
end of the last day of such taxable year and (ii) a statement from the Company setting forth whether or not, so far as the Company is aware, any Group Company was a CFC during such taxable year. Upon a determination by the Company, any Investor
or any Taxing Authority that any Group Company is a CFC for any taxable year, the Company will provide prompt written notice to each Investor, and shall furnish to each Investor, on a timely basis, all information reasonably requested by such
Investor that is reasonably necessary to satisfy the United States income tax return filing requirements of such Investor (or its owners) arising from its divestment in the Company and relating to any Group Company’s classification as a CFC and
the amount, if any, of any Subpart F income (within the meaning of the Code) of any Group Company. 

  

	11.7	 Each Group Company shall make due inquiry on at least an annual basis regarding its status as a PFIC, and if the Company determines that that any such
entity has become a PFIC, or that there is a likelihood of any such entity being classified as a PFIC for any taxable year, the Company shall promptly notify each Investor of such status or risk, as the case may be. The Company agrees to make
available to each investor upon request, the books and records of each Group Company, and to provide such information reasonably requested by any Investor that is pertinent to such Group Company’s status or potential status as a PFIC. Upon a
determination by the Company, any Investor or any Taxing Authority that any Group Company has been or is likely to become a PFIC, the Company will provide each Investor with all information reasonably requested by such Investor that is in the
Company’s possession to permit such Investor (and its owners) to (a) accurately prepare all tax returns and comply with any reporting requirements as a result of such determination and (b) make any election (including, without
limitation, a “qualified electing fund” election under Section 1295 of the Code), with respect to such 

  
 25 

	 	
Group Company, and comply with any reporting or other requirements incident to such election. If a determination is made by the Company, any Investor or any Taxing Authority that any Group
Company is a PFIC for a particular year, then for such year and for each year thereafter for which such Group Company is a PFIC, the Company will also provide each Investor that so requests with a completed “PFIC Annual Information
Statement” as required by United States Treasury Regulations Section 1.1295-1(g) and otherwise complying with applicable United States Treasury Regulations requirements. 

 

	11.8	The Company shall provide any information and assistance reasonably requested by the Investor that is reasonably necessary for the Investor (and any of its owners) to file its tax returns. 

 

	11.9	The Company shall use its reasonable endeavours not to become (or permit any Group Company to become) a PFIC. The Company shall notify the Investors prior to any issuance, dividend, or other distribution of Company
shares by the Company that would reasonably be expected to result in the Company or any Group Company becoming a CFC. 

  

	11.10	As soon as reasonably practicable following the date hereof, the Company shall use its reasonable endeavours to amend the Iron Mountain Contract to remove any restriction, mutation or consent right on or relating to a
Sale on terms reasonably satisfactory to the Insight Director; provided, however, that if me Company shall not have amended the Iron Mountain Contract in accordance with the terms hereof by October 7, 2013 (the “End
Date”‘), then the Company shall take all action necessary to terminate the Iron Mountain Contract, including by delivering a notice of termination to Iron Mountain by no later than the End Date in accordance with the terms of the Iron
Mountain Contract unless such obligation is waived by the Insight Director prior to the End Date. 

  

	12.	Sale or IPO 

  

	12.1	The parties agree to keep one another informed of all and any developments which might lead to any Sale or IPO. 

  

	12.2	Each party acknowledges and agrees that upon a Sale or IPO the Investors shall not be obliged to give warranties or indemnities (except a warranty as to title to the shares held by such Investor). 

 

	12.3	If a Sale or IPO is not achieved by the fifth anniversary of Completion then the Company shall, if required by an Investor Majority at the Company’s expense, appoint a professional adviser (to be agreed with the
prior sanction of an Insight Director Consent and an Index Director Consent) on a discreet mandate by way of a consultative process with the Board to report on exit opportunities and strategy and copies of such reports shall be made available to the
Investors and the Founders (at the Company’s cost). 

  

	12.4	It is hereby agreed by die parties that, on a IPO, the Shareholders shall: 

  

	 	(a)	to the extent required by: 

  

	 	(i)	the Listing Rules; or 

  
 26 

	 	(ii)	the Securities Act; or 

  

	 	(iii)	any equivalent requirements of any other recognised investment exchange (as defined in the Financial Services and Markets Act 2000), 

retain such number of their shares in the Company held at the time of the IPO for such period after IPO as is required by the Listing Rules,
the Securities Act or the. rules and requirements of the relevant recognised investment exchange; and 
  

	 	(b)	have regard to the recommendation of the Company’s brokers on an IPO in determining their respective sale of shares upon the Company’s IPO and shall make such determination with a view to ensuring the success
of the IPO. 

  

	13.	Further Issues and transfer of Shares 

  

	13.1	Each of the Founders and Existing Shareholders undertakes to the Investors that he shall not, and shall not agree to, transfer, mortgage, charge or otherwise dispose of the whole or any part of his interest in, or grant
any option or other rights over, any shares in the capital of the Company to any person except where permitted by or in accordance with the New Articles and this Agreement. 

 

	13.2	Save with the consent of the Board (acting with Insight Director Consent, Index Director Consent and Founder Consent), none of the parties to this Agreement shall transfer, mortgage, charge or otherwise dispose of the
whole or any part of his interest in, or grant any option or other rights over, any shares in the capital of the Company nor shall the Company issue any shares or equity securities (other than B Ordinary Shares), to any person who is not a party to
this Agreement without first obtaining from the transferee or subscriber a Deed of Adherence. 

  

	13.3	The Deed of Adherence shall be in favour of the other parties to this Agreement and shall be delivered to the Company at its registered office and to the Insight Investors and die Index Investors. No share transfer or
issue of shares shall be registered unless such Deed of Adherence has been delivered. 

  

	14.	Restrictive covenants 

  

	14.1	For the purpose of assuring to the Investors and the Company the value of the Business and any other business which may be conducted by a Restricted Company from time to time and the full benefit of the goodwill of the
business of each Restricted Company and protecting Confidential Information and workforce stability, each of the Founders hereby severally undertakes and covenants with the Investors and the Company that (save for any interest in the shares or other
securities of a company traded on a securities market so long as such interest does not extend to more than 5 per cent of the issued share capital of 

  
 27 

	 	
the company or the class of securities concerned or, save with the written consent of an Investor Majority, the Insight Director and the Dawn Capital Director) he shall not: 

 

	 	(a)	while he is a director or employee of, or a consultant to, any Restricted Company carry on or be concerned, engaged or interested directly or indirectly (in any capacity whatsoever) hi any trade or business competing
with the trade or business of any Restricted Company as carried on at the time or, in relation to any trade or business of any Restricted Company at any time during the previous two years; or 

 

	 	(b)	during the period of 18 months commencing on the Relevant Date: 

  

	 	(i)	within the Restricted Area carry on or be concerned, engaged or interested directly or indirectly in any capacity whatsoever in any business or entity competing with the business carried on by any Restricted Company; or

  

	 	(ii)	either on his own behalf or in any other capacity whatsoever directly or indirectly do or say anything which may lead to any person (including any agent supplier or distributor) ceasing to do business with any
Restricted Company on substantially the same terms as previously (or at all) or reducing the business which they do with any Restricted Company; or 

  

	 	(iii)	either on his own behalf or on behalf of any business or entity competing with any Restricted Company within the Restricted Area directly or indirectly endeavour to entice away from any Restricted Company or solicit
business in respect of goods or services which any Restricted Company offers or plans to offer at the Termination Date from any person, firm or company who was a client or customer or Prospective Customer of any Restricted Company during the Period
and with whom (in each case) who shall during the Period have had direct dealings on behalf of a Restricted Company or about which he has received Confidential Information; or 

 

	 	(iv)	either on his own behalf or on behalf of any business or entity competing with any Restricted Company within the Restricted Area directly or indirectly have business dealings in respect of goods or services which any
Restricted Company offers or plans to offer at the Termination Date to any person, firm or company who was a client or customer or Prospective Customer of any Restricted Company during the Period and with whom (in each case) he shall during die
Period have had direct dealings on behalf of any Restricted Company or about which he has received Confidential Information; 

  

	 	(v)	either on his own behalf or in any other capacity whatsoever directly or indirectly employ, engage or induce, or seek to induce, to leave the service of any Restricted Company any Senior Employee with whom he shall have
had dealings during the Period or about which he has Confidential Information whether or not such person would commit any breach of his contract of employment by reason of so leaving the service of die Restricted Company or otherwise; or

  
 28 

	 	(c)	at any time after the Termination Date represent himself as being in any way currently connected with or interested in the business of any Restricted Company (other than as a shareholder, director, employee or
consultant if that be the case). 

  

	14.2	Each of the restrictions contained in each paragraph of clause 14.1 is separate and distinct and is to be construed separately from the other such restrictions. Each of the Founders hereby acknowledges that be considers
such restrictions to be reasonable both individually and in the aggregate and that the duration extent and application of each of such restrictions are no greater than is necessary for the protection of the goodwill of the businesses of each
Restricted Company, Confidential Information and the stability of the workforce and that the consideration paid by the Investors for the New Shares applied for in this Agreement takes into account and adequately compensates him for any restriction
or restraint imposed thereby. However, if any such restriction shall be found to be void or unenforceable but would be valid or enforceable if some part or parts thereof were deleted or the period or area of application reduced, each of the Founders
hereby agrees that such restriction shall apply with such modification as may be necessary to make it valid. 

  

	15.	Confidentiality 

  

	15.1	Subject to clauses 9.7 to 9.11 (inclusive), each of the parties agrees to keep secret and confidential and not to make use of disclose or divulge to any third party or to enable or cause any person to become aware of
(save in the proper performance of the Founder’s duties for the Company) any Confidential Information but excluding any information which is or which comes into the public domain (otherwise than through the wrongful disclosure of any party) or
which they are required to disclose by law or by the rules of any regulatory body to which the Company is subject. Nothing in this clause shad prevent any Founder from making a “protected disclosure” pursuant to the Public Interest
Disclosure Act 1998 or equivalent legislation elsewhere. 

  

	15.2	The Company acknowledges that at least same of the Investors are in the business of venture capital investing and therefore review die business plans and related proprietary information of many enterprises, including
enterprises which may have products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing in any particular enterprise whether or not
such enterprise has products or services which compete with those of the Company, provided that the Investor does not directly or indirectly disclose or otherwise make available any Confidential Information to any such enterprise. 

 

	16.	Announcements 

  

	16.1	Except in accordance with clauses 9.7 to 9.11 (inclusive) or 16.2 and except for the press release in the agreed form (if any), the parties shall not make any public announcement or issue a press release or respond to
any enquiry from the press or other media concerning or relating to this Agreement or its subject matter (including but not limited to the Investors’ investment in the Company) or any ancillary matter. 

  
 29 

	16.2	Notwithstanding clause 16.1, any party may: 

  

	 	(a)	make any press release to the effect that it has made an investment in the Company and/or that it is a shareholder in the Company and/or otherwise with the prior written consent of an Investor Majority, the Dawn Capital
Director, the Insight Director and the Board; or 

  

	 	(b)	if and to the extent required by: 

  

	 	(i)	law; or 

  

	 	(ii)	any securities exchange on which any party’s securities are listed or traded; or 

  

	 	(iii)	any regulatory or governmental or other authority with relevant powers to which any party is subject or submits, whether or not the requirement has the force of law, make or permit to be made an announcement concerning
or relating to this Agreement or its subject matter or any ancillary matter. 

  

	17.	Costs and expenses 

  

	17.1	The Company shall pay at Completion (and agrees that the Series B Investors or the Series B Investors’ Solicitors on behalf of the Series B Investors may deduct from the sums payable in accordance with clause
4.2(a)) all legal, accounting and due diligence fees and disbursements of the Series B Investors in relation to the negotiation, preparation, execution, performance and implementation of this Agreement and each document referred to in it and other
agreements forming pan of the transaction up to a maximum amount of US$ 100,000. Any such fees and disbursements which are not deducted by the Series B Investors or the Series B Investors’ Solicitors on behalf of the Series B Investors at
Completion shall be reimbursed promptly upon request by the Series B Investors (up to the aggregate limit referred to in this clause 17.1). 

  

	17.2	The Company and the other parties shall bear their own costs and disbursements incurred in the negotiations leading up to and in the preparation of this Agreement and of matters incidental to this Agreement.

  

	18.	Survival and cessation of obligations of the Founders 

 The obligations on a Founder
under clauses 14 (restrictive covenants) and 15 (confidentiality) shall survive any transfer by him of all or any shares in the Company and shall survive him ceasing to be a director or employee of or consultant to any Group Company but otherwise
upon a Founder ceasing to hold shares in die Company and ceasing to be a director or employee of or consultant to any Group Company he shall have no further obligation or liability hereunder but without prejudice to the due performance by him of all
obligations up to die date of such cessation. 

  
 30 

	19.	Effect of ceasing to hold Shares 

 Save as set out in clause 18, a party shall cease to
be a party to this Agreement for the purpose of receiving benefits and enforcing his rights with effect from the date he ceases to hold or beneficially own any shares in the capital of the Company (but without prejudice to any benefits and rights
enjoyed prior to such cessation). 
  

	20.	Cumulative remedies 

 The rights, powers, privileges and remedies conferred upon the
Investors in this Agreement are cumulative and are not exclusive of any other rights, powers, privileges or remedies provided by law. 
  

	21.	Waiver 

 The express or implied waiver by any party to this Agreement of any of its
rights or remedies arising under this Agreement or by law shall not constitute a continuing waiver of the right or remedy waived or a waiver of any other right or remedy; provided, however, that if a claim is made under the Existing SSA with respect
to any matter for which the Series B Investors would also be entitled to make a Claim under this Agreement, then any damages paid in respect of such Claim shall be paid among the Series B Investors and the Series A Investors proportionately to their
respective holdings of Shares. 
  

	22.	Termination of Existing Agreements 

  

	22.1	Save for clause 6.1 of file Existing SSA which shall continue in full force and effect, the parties hereto acknowledge and agree that the Existing SSA shall terminate with immediate effect upon Completion.

  

	22.2	Each of the parties (other than the Company) to the Existing SSA hereby irrevocably: 

  

	 	22.2.1	acknowledges and agrees that it has no claim (actual or contingent) or right against the Company or any of its directors, employees, officers, shareholders, agents, or representatives (together, “Connected
Persons”) under, in respect of, related to, arising from or connected with the Existing SSA; and 

  

	 	22.2.2	waives, releases and discharges any and all present causes of action, disputes, controversies, claims, counterclaims, set-offs, debts, demands, obligations, costs (whether legal or otherwise), expenses, fees and
liabilities, whether they are contingent or not, which are in existence and/or leave arisen at the date hereof, whether or not they have already been asserted by such party or any other person or entity and whether or not known to them, which are
owed, due from, payable by or hi respect of which there is any liability on die part of the Company and/or any of its Connected Persons, under, in respect of, related to, arising from or connected with the Existing SSA. 

  
 31 

	23.	Entire agreement 

  

	23.1	This Agreement and the documents referred to or incorporated in it constitute the entire agreement between the parties relating to the subject matter of this Agreement and supersedes and extinguishes any prior drafts,
agreements, undertakings, representations, warranties and arrangements of any nature whatsoever, whether or not in writing, between the parties in relation to the subject matter of this Agreement. 

 

	23.2	Each of the Investors confirms and undertakes to each other Investors that there are no other arrangements or documentation relating to their subscription for the Preferred Shares (including the remuneration of any
Investor appointee) save as set out or expressly referred to in this Agreement and/or the New Articles). 

  

	23.3	Each of the parties acknowledges and agrees that it has not entered into this Agreement in reliance on any statement or representation of any person (whether a party to this Agreement or not) other than as expressly
incorporated in this Agreement and the documents referred to or incorporated in this Agreement 

  

	23.4	Without limiting the generality of the foregoing, each of the parties irrevocably and unconditionally waives any right or remedy it may have to claim damages and/or to rescind this Agreement by reason of any
misrepresentation (other than a fraudulent misrepresentation) having been made to it by any person (whether party to this Agreement or not) and upon which it has relied in entering into this Agreement, 

 

	23.5	Each of the parties acknowledges and agrees that the only cause of action available to it under die terms of this Agreement and the documents referred to or incorporated in this Agreement shall be for breach of
contract. 

  

	23.6	Nothing contained in this Agreement or in any other document referred to or incorporated in it shall be read or construed as excluding any liability or remedy as a result of fraud. 

 

	24.	Variation 

 Any variation of this Agreement is valid only if it is in writing and signed
by the Company and the parties to this Agreement who hold at least ninety percent (90%) of the aggregate of the issued share capital of the Company held by the parties to this Agreement (including an Investor Majority, a Series B Majority, the
Founders, and a Dawn Capital Consent), in which event such change shall be binding against all of the parties hereto provided that if such change would impose any new obligations on a party or increase any existing obligation, the consent of the
affected party to such change shall be specifically required. 
  

	25.	No partnership 

 Nothing in this Agreement is intended to or shall be construed as
establishing or implying any partnership of any kind between the parties. 

  
 32 

	26.	Assignment and transfer 

  

	26.1	Subject to clause 26.3, this Agreement is personal to the parties and no party shall: 

  

	 	(a)	assign any of its rights under this Agreement; or 

  

	 	(b)	transfer any of its obligations under this Agreement; or 

  

	 	(c)	sub-contract or delegate any of its obligations under this Agreement; or 

  

	 	(d)	charge or deal in any other manner with this Agreement or any of its rights or obligations. 

  

	26.2	Any purported assignment, transfer, sub-contracting, delegation, charging or dealing in contravention of clause 26.3 shall be ineffective. 

 

	26.3	An Investor may assign the whole or part of any of its rights in this Agreement to any person who has received a transfer of shares in the capital of the Company from such Investor in accordance with the New Articles
and has executed a Deed of Adherence. 

  

	27.	Rights of third parties 

  

	27.1	Subject to clause 272, this Agreement does not confer any lights on any person or party (other than the parties to this Agreement) pursuant to the Contracts (Rights of Third Parties) Act 1999. 

 

	27.2	The general partner of an Investor or the management company authorised from time to time to act on behalf of an Investor or another person or persons nominated by an investor, shall be entitled to enforce all of the
rights and benefits under Ibis Agreement on behalf of such Investor at all times as if party to this Agreement. 

  

	28.	Conflict between agreements 

 Subject to any applicable law, in the event of any
ambiguity or conflict between this Agreement and the New Articles, the terms of this Agreement shall prevail as between the Shareholders and in such event the Shareholders shall procure such modification to the New Articles as shall be necessary.

  

	29.	Counterparts 

 This Agreement may be executed in any number of counterparts, each of
which shall constitute an original, and all the counterparts shall together constitute one and the same agreement 
  

	30.	Notices 

  

	30.1	Any communication and/or information to be given in connection with this Agreement shall be in writing in English and shall either be delivered by hand or sent by first class post or fax or email or in electronic form:

  

	 	(a)	to any company which is a party at its registered office (or such other address as it may notify to the other parties to this Agreement for such purpose); or 

  
 33 

	 	(b)	to any individual who is a party at the address of that individual shown in Schedule 1; or 

  

	 	(c)	to an Investor at the address of that Investor shown in Schedule 1, 

 (or in each such case such
other address as the recipient may notify to the other parties for such purpose). 
  

	30.2	A communication sent according to clause 30.1 shall be deemed to have been received: 

  

	 	(a)	if delivered by hand, at the time of delivery; or 

  

	 	(b)	if sent by pre-paid first class post, on the second day after posting; or 

  

	 	(c)	if sent by fax, email or other electronic communication, at the time of completion of transmission by the sender; except that if a communication is received between 17.30 London, UK time on a Business Day and 09:30
London, UK time on the next Business Day, it shall be deemed to have been received at 09:30 London, UK time on the second of such Business Days. 

  

	31.	Severance 

  

	31.1	If any provision of this Agreement is held to be invalid or unenforceable by any judicial or other competent authority, all other provisions of this Agreement will remain in full force and effect and will not in any way
be impaired. 

  

	31.2	If any provision of this Agreement is held to be invalid or unenforceable but would be valid or enforceable if some part of the provision were deleted, the provision in question will apply with the minimum modifications
necessary to make it valid and enforceable. 

  

	32.	Governing law 

 This Agreement and any dispute or claim arising out of, or in connection
with, it or its subject matter or formation (including any dispute or claim relating to no ii-contractual obligations) shall be governed by and construed in accordance with English law. 

 

	33.	Jurisdiction 

 The parties irrevocably agree that the courts of England have exclusive
jurisdiction to settle any dispute or claim arising out of, or in connection with, this Agreement or its subject matter or formation (including any dispute or claim relating to non-contractual obligations). 

  
 34 

	34.	Confirmation by Founders and Existing Shareholders 

 Each of the Founders and Existing
Shareholders confirms to the Investors that, for the purposes of entering into the transactions contemplated by this Agreement: 
  

	 	(a)	he has entered into such transactions entirely on the basis of his own assessment of the risks and effect thereof; and 

  

	 	(b)	he is owed no duty of care or other obligation by the Investors; and 

  

	 	(c)	insofar as he is owed any such duty or obligation (whether in contract, tort or otherwise) by the Investors he hereby waives, to the extent permitted by law, any rights (save in the case of any fraudulent
misrepresentation) which he may have in respect of such duty or obligation. 

  

	35.	Regulatory matters 

 No Investor or general partner of any Investor or management company
authorised from time to time to act on behalf of any Investor is acting for or advising any other party to the transaction that is the subject of this Agreement and accordingly no such Investor, general partner of any Investor and/or management
company of any Investor (as appropriate) shall be responsible to any other party for providing any protection afforded to any client (as defined in the Glossary to the FSA Handbook of rules and guidance) for any Investor. 

  
 35 

 Schedule 1 

Part 1: The Series B Investors 
  

					
	 	  	 Name
	  	 Address

	1	  	Insight Venture Partners VTJ, L-P.	  	680 Fifth Avenue, New York, NY 10019, USA
			
	2	  	Insight Venture Partners (Cayman) VII, LP.	  	680 Fifth Avenue, New York, NY 10019, USA
			
	3	  	Insight Venture Partners VII (Co-Investors), L.P.	  	680 Fifth Avenue, New York, NY 10019, USA
			
	4	  	Insight Venture Partners (Delaware) VII, LP.	  	680 Fifth Avenue, New York, NY 10019, USA
			
	5	  	Insight Venture Partners Coinvestment Fund II, L.P.	  	680 Fifth Avenue, New York, NY 10019, USA

 Part 2: The Series A Investors 

 

					
	 	  	 Name
	  	 Address

	1	  	Index Ventures V (Jersey), LP.	  	Index Ventures Associates V Limited, Whiteley Chambers, Don Street, St. Helier, Jersey, JE4 9WG, Channel Islands
			
	2	  	Index Ventures V Parallel Entrepreneur Fund (Jersey), I*P.	  	Index Ventures Associates V Limited, Whiteley Chambers, Don Street, St Helier, Jersey, JE4 9WC-, Channel Islands
			
	3	  	Yucca Partners LP. Jersey Branch	  	C/o Ogier Employee Benefit Services Limited, Whiteley Chambers, Don Street, St. Helier, Jersey, JE4 9WQ, Channel Islands
			
	4	  	Dawn Enterprise Capital Fund LP	  	C/o Dawn Capital LLP, 14 Buckingham Street, London WC2N6DF
			
	5	  	Dawn Mimecast (II) Holdings Limited	  	PO Box 3175, Road Town, Tortola, British Virgin Islands Part 3: The Founders

 Part 3: The Founders 
  

					
	 	  	 Name
	  	 Address

	1	  	Neil Murray	  	Stoke Gap House, Ashton Road, Stoke Brueme, Normaniptonshiro, NN12 7AM
			
	2	  	Peter Bauer	  	78 Main Street, Southborough, MA 01772, USA

  
 36 

 Part 4: The Existing Shareholders 

 

					
	 	  	 Name
	  	 Address

	1	  	Rock Trustees as trustees of the Butterworth Trust	  	Rock House, Sark, GY9 OSD
	2	  	Dawn Enterprise Capital Fund LP	  	c/o Dawn Capital LLP, 14 Buckingham Street, London WC2N 6DF
	3	  	Dawn Mimecast Holdings Limited	  	PO Box 3175, Road Town, Tortola, British Virgin Islands
	4	  	Dawn Mimecast (II) Holdings Limited	  	PO Box 3175, Road Town, Tortola, British Virgin Islands
	5	  	James Espey	  	17 Somerset Road, Wimbledon. London SN19 5JZ
	6	  	Mark Bilbe	  	112 Puritan Lane, Sudbury Massachusetts, USA 01766
	7	  	Osprey Heights Limited	  	Genesis Trust & Corporate Services Limited, Compass Centre, Shedden Road, PO Box 448 GT George Town, Grand Cayman
	8	  	Roger Fullerton	  	Chalet la Montfenine, Cret de la Prairie 27, Chesieres, Vaud, 1885, Switzerland

  
 37 

 Schedule 2 

Part 1: Particulars of the Company 
  

			
	Registered number:	  	04698693
		
	Registered office:	  	 2-8 Balfe Street,
 London

N1 9EG

		
	Directors:	  	 Peter Cyril Bauer
 Peter Andrew

James Campbell
 Bernard Dalle

Norman Benito Fiore
 Christopher Francis

FitzGerald Michael
 Cary Hedger

Neil Hamilton Murray

		
	Secretary:	  	Peter Andrew James Campbell
		
	Accounting reference date:	  	31/03
		
	Charges:	  	Rent Deposit Deed registered on 23/02/2008 entered into with Land & Equity Holdings Limited
		
		  	Rent Deposit Deed registered on 12/06/2008 entered into with Land & Equity Holdings Limited
		
		  	Rent Deposit Deed registered on 15/07/2009 entered into with Land & Equity Holdings Limited
		
		  	Debenture registered on 01/02/2012 entered into with Silicon Valley Bank
		
	Auditors:	  	PricewaterhouseCoopers LLP
		
	Authorised share capital:	  	 10,000,000 Founder Shares of £0.00001 each

40,000,000 A Ordinary Shares of £0.00001 each
 50,000,000 B
Ordinary Share of £0.00001 each
 330,000 C Ordinary Shares of £0.00001 each

4,231,090 Series A Preferred Shares of £0.00001 each

		
	Issued share capital:	  	 5,817,021 Founder Shares of £0.00001 each

4,133,801 A Ordinary Shares of £0.00001 each
 3,379,315 B
Ordinary Shares of £0.00001 each
 330,000 C Ordinary Shares of £0.00001 each

4231,090 Series A Preferred Shares of £0.00001 each

  
 38 

 Part 2: Particulars of the Subsidiaries 

 

			
	Name of company:	  	Mimecast Services Limited
		
	Registered number:	  	4901524
		
	Registered office:	  	2-8 Balfe Street, London, N1 9EG
		
	Directors:	  	 Peter Andrew James Campbell
  

Peter Cyril Bauer
  

Neil Hamilton Murray

		
	Secretary:	  	Peter Andrew James Campbell
		
	Accounting reference date:	  	31 March
		
	Charges:	  	None
		
	Auditors:	  	PricewaterhouseCoopers LLP
		
	Authorised share capital:	  	1,000 Ordinary shares of £0.01 each
		
	Issued share capital:	  	100 Ordinary shares of £0.01 each
		
	Name of company:	  	Mimecast North America, Inc.
		
	Registered number:	  	EIN: 26-0851633
		
	Registered office:	  	16192 Coastal Highway, Lewes, Delaware 199589776 USA
		
	Directors:	  	 Peter Cyril Bauer
  

Peter Andrew
  

James Campbell

		
	Secretary:	  	Peter Andrew James Campbell
		
	Accounting reference date:	  	31 March
		
	Charges:	  	None
		
	Auditors:	  	PricewaterhouseCoopers LLP
		
	Authorised share capital:	  	1500 no par value shares for an amount of $1
		
	Issued share capital:	  	100 no par value shares for an amount of $1
		
	Name of company:	  	Mimecast South Africa (Pry) Ltd
		
	Registered number:	  	2004/000965/07
		
	Registered office:	  	Upper Grayston Office Park, 150 Linden Road, Strafliavon, Sandton, 2032, RSA
		
	Directors:	  	Peter Andrew James Campbell Garth Wittles

  
 39 

			
	Secretary:	  	Ulf Maske
		
	Accounting reference date:	  	31 March
		
	Charges:	  	None
		
	Auditors:	  	PricewaterhouseCoopers LLP
		
	Authorised share capital:	  	1,000 Ordinary shares of ZAR 1
		
	Issued share capital:	  	1 Ordinary shares of ZAR 1
		
	Name of company:	  	Mimecast Offshore Limited
		
	Registered number:	  	6150
		
	Registered office:	  	c/o Foreshore Limited, The Powerhouse, Queens Road, St, Helier, Jersey, JE2 3AP
		
	Directors:	  	 Robin James Hagerman
  

Graeme Russell Harker

		
	Secretary:	  	Rock Trustees Limited
		
	Accounting reference date:	  	31 March
		
	Charges:	  	None
		
	Auditors:	  	PricewaterhouseCoopers LLP
		
	Authorised share capital:	  	10,000 Ordinary shares of £1
		
	Issued share capital:	  	1 Ordinary share of £1
		
	Name of company:	  	Mimecast Nordics AB Ltd
		
	Registered number:	  	556762-6733
		
	Registered office:	  	Settcrwalls Advokatbyra AB, Box 1050, Se-101 39, Stockholm, Sweden & C/O Navista AB, Box 1600, 183 16 TABY
		
	Directors:	  	 Peter Andrew James Campbell
  

Alan Kenny

		
	Secretary:	  	N/A
		
	Accounting reference date:	  	30 June
		
	Charges:	  	None
		
	Auditors:	  	PricewaterhouseCoopers LLP
		
	Authorised share capital:	  	N/A
		
	Issued share capital:	  	100 share of 100 SEK

  
 40 

 Schedule 3 

Part 1: Members of the Company - pre-Completion 
  

					
	 Member
	  	Number of Founder Shares held	 
	 Peter Bauer
	  	 	1,812,447	  
	 Butterworth Trust
	  	 	1,500,000	  
	 Neil Murray
	  	 	2,504,574	  
		  	  
	  
	 
	 TOTAL
	  	 	5,817,021	  
		  	  
	  
	 
		
	 Member
	  	Number or A Ordinary Shares held	 
	 Roger Fullerton
	  	 	625281	  
	 James Espey
	  	 	1,000,000	  
	 Mark Bilbe
	  	 	85,000	  
	 Osprey Heights Ltd
	  	 	639,000	  
	 Dawn Enterprise Capital Fund LP
	  	 	1,348,300	  
	 Dawn Mimecast Holdings Limited
	  	 	436,220	  
		  	  
	  
	 
	 TOTAL
	  	 	4,133,801	  
		  	  
	  
	 
		
	 Member
	  	Number of B Ordinary Shares held	 
	 Osprey Heights Ltd
	  	 	270,044	  
	 Hibiscus Limited
	  	 	399,405	  
	 Maitland Trustees
	  	 	129,000	  
	 Grant Stein
	  	 	118,185	  
	 Dandy Investments
	  	 	270,000	  
	 Nova Investment Management Limited
	  	 	140,000	  
	 David Titcombe
	  	 	180,330	  
	 Matthew FitzGerald
	  	 	148,340	  
	 Ian Taylor
	  	 	88,030	  
	 Julie Turner
	  	 	58,680	  
	 Kerry Baris
	  	 	58,680	  
	 Nick Malaczynski
	  	 	58,680	  
	 Robert Juxon
	  	 	37,600	  

  
 41 

					
	David Juxon	  	 	45,860	  
	Robert Court	  	 	260200	  
	Santa Anita Limited	  	 	58,680	  
	Jill FitzGerald	  	 	91,730	  
	David Lyons	  	 	58,680	  
	Clive Jordan	  	 	44,540	  
	Louise Gafmey	  	 	44,540	  
	Deepak Kumaraswamy	  	 	19,340	  
	Mark Lewis and Fiona Nadaraja	  	 	176,050	  
	CIBC Bank and Trust Company (Cayman) Limited	  	 	26,160	  
	Dramatis Limited	  	 	102,950	  
	Richard Thomas	  	 	22,230	  
	Samantha Hamilton	  	 	9,120	  
	Milo Trust	  	 	18,220	  
	Helen Hedger	  	 	40,000	  
	Mike Hedger	  	 	99,140	  
	James Adrian Rory MacEwen	  	 	4,140	  
	Alexander Keswick MacEwen	  	 	4,140	  
	Charles Julian Speers	  	 	4,140	  
	Ross Jennings	  	 	17,968	  
	Henry Beckwith	  	 	6,620	  
	Simon Piers Beckwith	  	 	6,620	  
	Sam Johnson-Hill	  	 	3310	  
	James Heddle	  	 	830	  
	Simon Charles Wragg	  	 	1,110	  
	Cedar Consulting (UK) Limited	  	 	24,910	  
	Earl Trust Company Ltd as Trustees of the Murdoch Trust	  	 	19280	  
	G M Trustees as Trustee of the BMD Trust	  	 	19,280	  
	Barton Court Limited	  	 	41,240	  

  
 42 

					
	 William Carey Evans
	  	 	33,690	  
	 Dramatis Limited
	  	 	2,480	  
	 Segal Universal Technologies S. A.
	  	 	8270	  
	 Brandon Bekkcr
	  	 	64,550	  
	 Ross Rennie
	  	 	10,000	  
	 Steve McKenzie
	  	 	66,660	  
	 Michael Taylor
	  	 	621,922	  
	 Paul Stafford
	  	 	18,220	  
	 Marzanne and Craig Fullcrton
	  	 	132,190	  
	 Ruslan Capital
	  	 	33,050	  
	 Dawn Mimecast Holdings Limited
	  	 	198,280	  
	 Dawn Mimecast (III) Holdings Limited
	  	 	1,279,688	  
	 Rafi International FZC LLC
	  	 	165,230	  
	 Samantha Marie Maske
	  	 	18,990	  
	 Mark Bilbe
	  	 	49,570	  
	 (Picter) Andre Hamman
	  	 	10,510	  
	 Orlando Scott-Cowley
	  	 	20,000	  
	 David Goldberg
	  	 	20,000	  
	 Jonathan Gale
	  	 	34,227	  
	 Stephen Thompson
	  	 	8,260	  
	 Madeleyne Shergoid
	  	 	9,750	  
	 Tim Pickard
	  	 	20,000	  
	 Grant Hodgkinson as Trustee of the Hodgkinson Family Trust
	  	 	32,504	  
	 Index Ventures V (Jersey) LP
	  	 	959,669	  
	 Index Ventures V Parallel Entrepreneur Fund
	  	 	7,769	  
	 Yucca Partners
	  	 	12,250	  
	 Inder Arya
	  	 	3,305	  
	 Rajiv Aria
	  	 	6,600	  
	 Merchant Investors (Trustee Services) Limited
	  	 	30,770	  

  
 43 

					
	 Alan Sutton
	  	 	19,231	  
	 Athanasios Missaikos
	  	 	19,231	  
	 Allan Cawood
	  	 	19,231	  
	 Jason Goodall
	  	 	19,231	  
	 Raoul Fraser
	  	 	9,616	  
	 Robert Suss
	  	 	19,231	  
	 Cherry Freeman
	  	 	9,616	  
	 Paul Kanereok
	  	 	9,616	  
	 Sandeep Patel
	  	 	3,847	  
	 Richard Mowbray
	  	 	8,172	  
	 Carlos Farjallah
	  	 	14,620	  
	 David Lashbrook
	  	 	7,823	  
	 Lynn Lashbrook
	  	 	15,647	  
	 Graeme Edwards
	  	 	39,350	  
	 Andrew Millar
	  	 	18260	  
	 R&H Trust Co (Jersey) Limited as trustee of The Ihchbold Trust
	  	 	20,930	  
	 Westwinds Grantees Limited as Trustees of the Ocean Trust
	  	 	22,040	  
	 BWSIPP Trustees Limited on Behalf of BW SEPP - Clough S - 5424
	  	 	100,000	  
	 Cannon Asset Management Limited as Trustees of The Francisan Trust (Paul Stafford)
	  	 	28,846	  
	 Genevieve Weynerowski
	  	 	3,305	  
	 Matthew Ravden
	  	 	30,342	  
	 Mohammed Naqui Mirza
	  	 	10,156	  
	 Harindcr Bhullar
	  	 	10,156	  
	 Sarah Kok
	  	 	22,000	  
	 JTC Trustees Limited as trustees of the Brandon Bekker Trust
	  	 	83,050	  
	 Corvus Limited
	  	 	499,270	  
	 Lauren Fletcher
	  	 	8,500	  

  
 44 

					
	 Johan Krugcr
	  	 	20,000	  
	 Mary Kay Roberto
	  	 	93,722	  
	 Jacqueline Osborne
	  	 	3,778	  
	 Ulf Maske
	  	 	4,900	  
	 Irmgard Maske
	  	 	5,013	  
	 Adam Towns
	  	 	4,957	  
	 Nigel Towns
	  	 	4,956	  
	 Laetitia Marie Guydot
	  	 	10,667	  
	 Jim Tui trustees as trustees of the Jim Tui family trust
	  	 	29,334	  
	 Mandy McKenzic
	  	 	11,765	  
	 Ken Greene
	  	 	12,500	  
		  	  
	  
	 
	 TOTAL
	  	 	8,379,315	  
		  	  
	  
	 

  

					
	 Member
	  	Number of Series a Preferred Shares held	 
	 Dawn Enterprise Capital Fund LP
	  	 	325,480	  
	 Dawn Mimecast (II) Holdings Limited
	  	 	196,900	  
	 Index Ventures V (Jersey) LP.
	  	 	3,633,050	  
	 Index Ventures V Parallel Entrepreneur Fund (Jersey) L.P.
	  	 	29,300	  
	 Yucca Partners
	  	 	46,360	  
		  	  
	  
	 
	 TOTAL
	  	 	4,231,090	  
		  	  
	  
	 
		
	 Member
	  	Number of C Ordinary Shares held	 
	 Peter Bauer
	  	 	180,000	  
	 Neil Murray
	  	 	150,000	  
		  	  
	  
	 
	 TOTAL
	  	 	330,000	  
		  	  
	  
	 

  
 45 

 Part 2: Members of the Company – post-Completion 

In addition to the members and shareholdings set out in Part 1 of Schedule 3 above, there will be the following additional members immediately following
Completion 
  

					
	 Member
	  	Number of Series B Preferred Shares held	 
	 Insight Venture Partners VII, L.P.
	  	 	1,290,384	  
	 Insight Venture Partners (Cayman) VII, LP.
	  	 	568,054	  
	 Insight Venture Partners VII (Co-Investors), LP.
	  	 	29,867	  
	 Insight Venture Partners (Delaware) VII, L.P.
	  	 	81,620	  
	 Insight Venture Partners Coinvestment Fund II, L.P.
	  	 	1,344,806	  
		  	  
	  
	 
	 TOTAL
	  	 	3,314,731	  
		  	  
	  
	 

 Parts 1 and 2 of this Schedule 3 do not reflect the exercise of options over 259,140 B Ordinary Shares, the issue of 53,330 B
Ordinary Shares to Brandon Bekker, the conversion of 500,000 Founder Shares into A Ordinary Shares or the transfer of any shares pursuant to the Sale and Purchase Deeds or the Cash Offer. 

  
 46 

 Schedule 4 

Conditions to Completion 
  

	(a)	the passing of directors’ and shareholders’ resolutions in the agreed form at a duly convened Board meeting and a general meeting or by shareholders’ written resolution to: 

 

	 	(i)	authorise the allotment of the New Shares and the Additional Shares; 

  

	 	(ii)	waive pre-emption rights in respect of the allotment and issue of the New Shares and the Additional Shares; and 

  

	 	(iii)	adopt the New Articles; 

  

	 	(b)	delivery to the Series B Investors of the Accounts and the Management Accounts; 

  

	 	(c)	delivery to the Series B Investors of the Disclosure Letter; 

  

	 	(d)	delivery to die Insight Investors of the Management Rights Letter duly executed by the Company; 

  

	 	(e)	delivery to the Insight Director of the Director indemnification Agreement with the Insight Director duly executed by the Company; 

  

	 	(f)	delivery to the Series B Investors of the Registration Rights Agreement; 

  

	 	(g)	delivery to the Insight Investors of the Sale and Purchase Deeds in respect of the shares being purchased by the Insight Investors; and 

 

	 	(h)	delivery to the Series B Investors of the Cash Offer (including Acceptance and Authority). 

  
 47 

 Schedule 5 

Completion Warranties 
  

	1.	Share capital 

  

	1.1	The persons listed in Part 1 of Schedule 3 are the legal and, so far as the Warrantor is aware, the beneficial owners of the number of Ordinary Shares set opposite their respective names in Part 1 of Schedule 3 and all
of the shares set out in Part 1 of Schedule 3 are fully paid and comprise the entire issued share capital of the Company. Save as set out in the appendix to this Agreement, none of the share capital of the Company (whether issued or unissued) is
under option or subject to any mortgage, charge (fixed or floating), pledge, lien, security, interest or other third party right (including rights of pre-emption) and no dividends or other rights or benefits have been declared, made or paid or
agreed to be declared, made or paid thereon. 

  

	1.2	The Founders are the legal and the beneficial owners of the number of Founder Shares set opposite their respective names in Part 1 of Schedule 3. 

 

	1.3	A current snare capitalisation table of the Company showing all of the issued shares of the Company together with all shares in respect of which options or warrants have been granted and all shares reserved for the
issue of options and warrants is appended to this Agreement. 

  

	1.4	After giving effect to the transactions contemplated hereby, the insight Investors shall jointly own up to 16.9 percent of the Fully Diluted Share Capital. 

 

	2.	Information 

  

	2.1	The information contained or referred to in the Introduction, Schedules 2, 3 and 8, the Existing Loan Note Schedule and the Employment Information Table is true, complete and accurate and not misleading.

  

	3.	Accounts 

  

	3.1	The Accounts have been prepared in accordance with accounting principles, standards and practices which are generally accepted in the United Kingdom and on the same basis and in accordance with the same accounting
policies as the corresponding accounts for the preceding three financial years, comply with the requirements of the Act and give a true and fair view of the state of affairs of the Company at the Accounts Date and of the profits and losses for the
period concerned. 

  

	3.2	The Accounts make proper provision for or, in the case of actual liabilities, properly disclose, note or take into account as at the Accounts Date: 

 

	 	(a)	all liabilities whether actual contingent or disputed; 

  

	 	(b)	all capital commitments whether actual or contingent; 

  
 48 

	 	(c)	all bad and doubtful debts; and 

  

	 	(d)	all Taxation. 

  

	3.3	The Accounts properly provide or reserve for all Taxation for which the Company was liable at the Accounts Date. 

  

	3.4	The profits (or losses) shown in the Accounts have not to a material extent been affected (except as disclosed therein) by any extraordinary or exceptional event or circumstance or by any other factor rendering such
profits unusually high or low, 

  

	4.	Management Accounts 

 The Management Accounts: 

 

	 	(a)	have been prepared in accordance with good accounting practice for the preparation of management accounts on a basis consistent with that upon which the management accounts of the Company for the period to the Accounts
Date were prepared; 

  

	 	(b)	reasonably reflect the financial affairs of the Company at the date to which they have been prepared and its results for the period covered by the Management Accounts; and 

 

	 	(c)	ore not inaccurate or misleading in any material respect. 

  

	5.	Events since the Accounts Date 

  

	5.1	Since the Accounts Date as regards each Group Company: 

  

	 	(a)	its business has been carried on in the ordinary course and so as to maintain the same as a going concern; 

  

	 	(b)	it has not acquired or disposed of or agreed to acquire or dispose of any business or any material asset (other man capital equipment in the ordinary course of the business carried on by it) or assumed or acquired any
material liability (including a contingent liability) which is not specifically referred to in the Management Accounts; 

  

	 	(c)	no dividend or other distribution (as defined by CTA) has been declared, made or paid to its members nor has it repaid any loan capital or other debenture; 

 

	 	(d)	no material change has been made (or agreed to be made) in the emoluments or other terms of employment of any of its employees who arc in receipt of remuneration in excess of £100,000 per annum or of any of
die directors of such Group Company nor has it paid any bonus or special remuneration to any such employee or any of its directors; 

  
 49 

	 	(e)	it has not borrowed monies (except in the ordinary course of the business carried on by it or from its bankers under agreed loan facilities); 

 

	 	(f)	there has not been any material deterioration in the financial position or prospects of the Business as currently operated (whether in consequence of normal trading or otherwise); 

 

	 	(g)	neither the trading nor the profitability of the Business as currently operated shows, as regards turnover, the state of order book, expenses and profit margins, any material deterioration or downturn by comparison with
the period ended on the Accounts Date; 

  

	 	(h)	no part of tire Business as currently operated has been effected to a material extent by the loss of any important customer, or of any source of supply or by the cancellation or loss of any order or contract or by any
other abnormal factor or event nor so far as the Warrantor is aware are there any circumstances likely to lead thereto; 

  

	 	(i)	no Key Employee has been dismissed or made redundant nor has any Group Company taken or omitted to take any action which would entitle any Key Employee to claim that he has been constructively dismissed; and

  

	 	(j)	there are no liabilities (including contingent liabilities) outstanding on the part of such Group Company other than those liabilities disclosed in the Accounts or incurred in the ordinary and proper course of business
since the Accounts Date which are similarly disclosed in the Management Accounts or in the books and records of such Group Company. 

  

	6.	Taxation 

  

	6.1	Each Group Company has duly and punctually made all returns and given or delivered all notices, accounts and information which ought to have been made to and is not involved in any dispute with any Taxing Authority
concerning any matter likely to affect in any way the liability (whether accrued, contingent or future) of it to Taxation and such Group Company is not aware of any matter which is likely to lead to such dispute. 

 

	6.2	Each Group Company has duly paid or fully provided for all Taxation for which it is liable and the Warrantor is not aware of any circumstances in which interest or penalties in respect of Taxation not duly paid are
likely to be charged against it in respect of any period prior to Completion. 

  

	6.3	No liability of any Group Company to Taxation, or to account for Taxation, has arisen or will arise up to Completion save for 

  

	 	(a)	corporation tax payable in respect of normal trading profits earned by it; 

  

	 	(b)	income tax deducted under PA YE regulations; 

  
 50 

	 	(c)	national insurance contributions in respect of cash emoluments; or 

  

	 	(d)	value added tax for which it is accountable to any Taxing Authority and which has where appropriate been deducted or charged and where due paid to the appropriate Taxing Authority. 

 

	6.4	No Group Company has entered into or been a party to any schemes or arrangements designed partly or wholly for the purpose of it or (so far as each of the Warrantor is aware) any other person unlawfully evading
Taxation. 

  

	6.5	All documents to which any Group Company is a party or which form part of such Group Company’s title to any asset owned or possessed by it or which such Group Company may need to enforce or produce in evidence in
the courts of the United Kingdom have been duly stamped and (where appropriate) adjudicated. 

  

	6.6	No directors, officers or employees of any Group Company have received from such Group Company any securities, interests in securities or securities options as defined in Part 7 of ITEPA. 

 

	6.7	No directors, employees or officers of any Group Company have received any securities or interests in securities from any Group Company in a form which is or is likely to be treated as a “readily convertible
asset” as defined in Section 702 of ITEPA. 

  

	6.8	All directors, officers or employees of each Group Company who have received any securities or interests in securities from each Group Company falling with Chapter 2 of Part 7 of ITEPA have entered into elections
jointly with the Company under Section 431(1) of ITEPA. 

  

	6.9	Each Group Company is a close company as defined in Section 439 of CTA and is not and has never been a close investment-holding company as defined in Section 34 of CTA. 

 

	6.10	No distribution within Section 1064 of CTA has been made by any Group Company and no loan or advance within Sections 455, 459 and 460 of CTA has been made (and remains outstanding) or agreed to, by such Group
Company, and such Group Company has not, since the Accounts Date, released or written off the whole or part of the debt in respect of any such loan or advance. 

  

	6.11	So far as tire Warrantor is aware, all acquisitions or disposals of assets by the Company and all supplies of services by and to the Company have occurred on arm’s length terms between unconnected persons and for a
consideration in cash at market value. 

  

	6.12	Each Group Company is registered for the purposes of the Value Added Taxes Act 1994. Each Group Company has complied with all statutory provisions, regulations and notices relating to VAT and has duly and punctually
accounted for and/or paid HMRC all amounts of VAT which it ought to have so accounted for and/or paid. 

  
 51 

	6.13	So far as the Warrantor is aware, after giving effect to the transactions contemplated hereby and by the Completion Conditions, none of the Group Companies will be a CFC or a PFIC. 

 

	7.	Litigation 

  

	7.1	No Group Company, and so far as the Warrantor is aware, no person for whose acts and defaults it may be vicariously liable, is at present engaged, or previously engaged since 22 December 2009, whether as claimant,
defendant or otherwise in any legal action, proceeding or arbitration which is either in progress or is threatened or, so far as the Warrantor is aware, is pending (other than as claimant in the collection of debts arising in the ordinary course of
the business carried on by it none of which exceeds £10,000 and which do not exceed £50,000 in aggregate) or is being prosecuted for any criminal offence and no governmental or official investigation or inquiry concerning the Company is
in progress or so far as the Warrantor is aware pending. 

  

	7.2	There are no circumstances known to the Warrantor likely to lead to any such claim or legal action, proceeding or arbitration (other than as aforesaid) prosecution, investigation or enquiry. 

 

	7.3	There are no outstanding claims, legal actions, proceedings or arbitrations under the Existing SSA. 

  

	8.	Properties 

  

	8.1	Each Group Company, as applicable, has a good and marketable tide to and is the sole legal and beneficial owner of each of the Properties as described in Schedule 8 and the particulars of the Properties as set out in
Schedule 8 are true and accurate in all material respects. With the exception of the Properties, none of the Group Companies does own, use or occupy any other land or building whether under a licence or otherwise. 

 

	8.2	Save for the charges listed in Schedule 2, each of the Properties is free from all leases, tenancies, options, licences, mortgages, charges, liens and Encumbrances and any agreement to create any of them.

  

	8.3	As far as the Warrantor is aware all covenants, obligations (including without limitation statutory obligations), restrictions and conditions affecting any of the Properties or the applicable Group Company as owner or
lessee thereof have been observed and performed and all outgoings (including rates) have been duly paid and so far as the Warrantor is aware all die Properties are insured by the reversionary landlord to their full reinstatement value.

  

	8.4	No Group Company has received any compulsory purchase orders or resolutions affecting any of the Properties or any proposal for such an order or resolution of which the Warrantor is aware, 

 

	8.5	All deeds and documents necessary to prove title to each of the Properties are in the possession of the Group Companies (or under the control of the Group Companies) and all Stamp Duty Land Tax has been or will be paid
and where 8.6 title to any of the Properties requires to be registered at the Land Registry it has been so registered with tide absolute. 

  
 52 

	8.6	No notice, order, agreement, action or proceedings affecting any of the Properties has been served or commenced or adversely affects the Properties and there are no disputes concerning any of the Properties with any
person and as far as die Warrantor is aware there are no circumstances now existing which are likely to result in any such notice, order, action, agreement or proceedings being served or commenced or any such dispute arising. 

 

	8.7	There is no actual or contingent liability on die part of any Group Company in relation to any real property other than the Properties including any actual or contingent liability as previous lessee or underlessee or
guarantor or surety or covenantor in relation to any lease or underlease. 

  

	9.	Intellectual Property 

  

	9.1	The Group Companies own or license all Intellectual Property necessary to operate the Business as currently operated. 

  

	9.2	The Group Companies have taken all reasonable steps necessary to protect all Intellectual Property and know-how used by them and which is material to the Business as currently operated and the Group Companies have not
themselves granted any rights to third parties in relation to any of their Intellectual Property (other than in the ordinary course of business). 

  

	9.3	So far as the Warrantor is aware, the operations of the Group Companies and any products or services supplied by them do not use or infringe the rights of any person or infringe any right of privacy and the Warrantor is
not aware of any claims or applications for registration which might be material for disclosure to the Series B Investors as an applicant for shares in the Company. 

 

	9.4	All Intellectual Property, which is or is likely to be material to the business of the Group Companies, is (or in the case of applications will be) legally and beneficially vested exclusively in the Group Companies (or
otherwise licensed to the Group Companies) and, so as far as the Warrantor is aware, valid and enforceable and, so as far as the Warrantor is aware, not subject to any claims of opposition from any third party. 

 

	9.5	No Intellectual Property in which any Group Company has any legal and beneficial interest and which is, or is likely to be, material to the business of the Group Companies is: 

 

	 	(a)	so far as the Warrantor is aware, being (or has been) infringed, misappropriated or used without permission by any other person; or 

  
 53 

	 	(b)	subject to any licence, estoppel or authority or similar right in favour of any other person, except in the ordinary course of business or otherwise as set out in the agreements listed in the Disclosure Letter.

  

	9.6	All Intellectual Property which is registered in the name of any Group Company, or in respect of which any Group Company has made application for registration, is: 

 

	 	(a)	listed and briefly described in the Disclosure Letter; 

  

	 	(b)	legally and beneficially vested in such Group Company; and 

  

	 	(c)	so far as the Warrantor is aware, valid and enforceable. 

  

	9.7	All renewal fees in respect of the registered Intellectual Property have been duly paid, and all other steps required for the maintenance and protection of the registered Intellectual Property have been taken, in any
jurisdiction in which they are registered. 

  

	9.8	So far as the Warrantor is aware, nothing has been done or omitted to be done whereby any of die Intellectual Property owned or used by any Group Company have ceased or might cease to be valid and enforceable or whereby
any person is or will be able to seek cancellation, rectification or any other modification of any registration of any such Intellectual Property. 

  

	9.9	So far as the Warrantor is aware, no other person has registered or applied to register in any country any invention, topography, copyright work, design, trade or service mark or name, trade secret or know-how or other
Intellectual Property made, or claimed to be owned, by any Group Company. 

  

	9.10	No Group Company has knowingly disclosed or permitted to be disclosed to any person (other than under the protection of confidentiality undertakings or to the Investors and to their agents, employees or professional
advisers) any of its know-how, trade secrets, confidential information or lists of customers or suppliers. 

  

	9.11	The copy of the standard terms and conditions of the Group Companies annexed to the Disclosure Letter are properly incorporated into any transaction conducted over the internet by die Group Companies and govern access
to and use of any internet website owned, operated or hosted by the Group Companies or through which die Group Companies conduct any of their business (“Company Website”). 

 

	9.12	So far as the Warrantor is aware, no domain names have been registered by any person which are similar to any trademarks, service marks, domain names or business or trading names used, created or owned by the Group
Companies. 

  

	9.13	So far as the Warrantor is aware, the contents of any Group Company Website comply with all laws and regulations and codes of practice in any applicable jurisdiction. 

  
 54 

	9.14	So far as the Warrantor is aware, there are no third party claims that any domain name registered by any Group Company is in infringement of a third party’s domain name or other Intellectual Property rights.

  

	10.	Assets, debts and stock 

  

	10.1	None of the book debts included in the Accounts, the Management Accounts or which have subsequently arisen have been outstanding for more than three months from then due dates for payment and all such debts have
realised or, so far as the Warrantor is aware, will realise in the normal course of collection their full value, save as provided in the Accounts, the Management Accounts or in the books of the Company. 

 

	10.2	None of the existing debt of any Group Company has been converted into Shares. 

  

	10.3	Save as set out in Schedule 2, no Group Company has granted any security over any part of its undertaking or assets other than liens arising in the ordinary course of business, 

 

	10.4	All assets used by and all debts due to any Group Company or which have otherwise been represented as being its property or due to it or used or held for the purposes of its business are at the date of Completion its
absolute property and none is the subject of any Encumbrance (save for the charges listed in Schedule 2 and save hi respect of liens arising in the normal course of trading) or the subject of any factoring arrangement, hire-purchase, retention of
title, conditional sale or credit sale agreement. 

  

	10.5	The present stock and work-in-progress of the Group Companies is in good condition and is (or will be once completed) capable of being sold profitably. 

 

	10.6	Each material asset needed for the proper conduct of the Business as currently operated is in good repair and working order (fair wear and tear excepted). 

 

	10.7	The assets of the Group Companies constitute all of the assets necessary to conduct the Business as it is currently conducted as of the date of Completion. 

 

	11.	Contracts with connected persons 

  

	11.1	There are no loans made by any Group Company to any of its directors or shareholders and/or any person connected with any of them and no debts or liabilities owing by any Group Company to any of its directors or
shareholders and/or any person connected with them as aforesaid. 

  

	11.2	There are no existing contracts or arrangements to which any Group Company is a party and in which any of its directors or shareholders and/or any person connected with any of them is interested other than this
Agreement and the Service Agreements. 

  

	11.3	There are no agreements between any of the Founders or between any of the Founders and any Group Company other than this Agreement and the Service Agreements. 

  
 55 

	11.4	No Founder nor any person connected with a Founder owns any property used by any Group Company. 

  

	12.	Employment arrangements 

  

	12.1	Details of all contracts of service or for services and other arrangements (including, without limitation, details of notice periods and all remuneration) of all officers, employees and consultants of the Group
Companies are set out in or copies thereof annexed to the Disclosure Letter. 

  

	12.2	There are no agreements or other arrangements (binding or otherwise) for collective bargaining or, so far as the Warrantor is aware, outstanding or anticipated claims or disputes between any Group Company and any trade
union or other body representing all or any of the employees of any Group Company. 

  

	12.3	No Group Company owes any amount to, or has any outstanding obligations in respect of, any of its present or former directors, employees or shareholders other than remuneration accrued during the month in which this
Agreement has been entered into. 

  

	12.4	No gratuitous payment has been made or promised in connection with the actual or proposed termination or suspension of employment of any present or former director or employee of any Group Company. 

 

	12.5	No variation to the terms of any contract of employment has been promised to any employee of any Group Company, 

  

	12.6	There are no legally enforceable agreements or arrangements for the payment of any pensions, allowances, lump sums or other like benefits on redundancy, retirement or on death or during periods of sickness or
disablement for the benefit of any director or former director or employee or former employee of any Group Company or for the benefit of the dependants of any such person. 

 

	13.	Statutory and legal requirements 

  

	13.1	All statutory, municipal, governmental, court and other requirements applicable to the carrying on of the business of the Group Companies, the formation, continuance in existence, creation and issue of securities,
management, property or operation of the Group Companies have been complied with in all material respects, and all permits, authorities, licences and consents have been obtained and all conditions applicable thereto complied with in all material
respects and so far as die Warrantor is aware there are no circumstances which are likely to lead to the suspension, alteration or cancellation of any such permits, authorities, licences or consents, nor is there any agreement which materially
restricts the fields within which the Group Companies may carry on their business. 

  

	13.2	No Group Company has committed or is liable for any criminal, illegal, unlawful, ultra vires or unauthorised act or breach of covenant, contract or statutory duty. 

  
 56 

	13.3	In respect of himself only (so that no Founder shall have any liability in respect of the breach by the other Founder of this Warranty), each Founder confirms that he has not: 

 

	 	(a)	been convicted of a criminal offence (except any road traffic offence not punished by a custodial sentence); 

  

	 	(b)	been disqualified from being a company director; or 

  

	 	(c)	given, or offered to give, a disqualification undertaking under section 1A of the Company Directors Disqualification Act 1986. 

  

	13.4	No person, not being a director of the Company, has any actual or ostensible authority, whether under a power of attorney, agency agreement or otherwise, to commit the Company to any obligation other than an obligation
of a nature which it is usual for it to incur in the ordinary course of its business. 

  

	13.5	In respect of any Personal Data processed by the Company, each Group Company, such Group Company; 

  

	 	(a)	has made all necessary registrations and notifications of its particulars in accordance with the Data Protection Legislation; 

  

	 	(b)	complies with the Data Protection Legislation (including but not limited to the Data Protection Principles) and any legally binding guidance notes or guidelines issued by the Information Commissioner; and

  

	 	(c)	has complied with any subject access requests made pursuant to the Data Protection Legislation. 

  

	13.6	In respect of any Personal Data processed by any Group Company, all details supplied to the Information Commissioner by such Group Company in relation to each application for registration or notification are, so far as
the Warrantor is aware, accurate and complete in all material respects and no notice of any kind has been received by any Company under any provision under any part of the Data Protection Legislation or any analogous legislation in any part of die
world. 

  

	14.	Records and registers 

 So far as the Warrantor is aware, the records (including computer
records), statutory books, registers, minute books and books of account of each Group Company are duly entered up and maintained in accordance with all legal requirements applicable thereto and contain true and accurate records of all matters
required to be dealt with therein and all such books and all records and documents (including documents of title) which are its property are in its possession or under its control and all accounts, documents and returns required to be delivered or
made to the Registrar of Companies leave been duly and correctly delivered or made and there has been no notice received by any Group Company of any proceedings to rectify the register of members of such Group Company and there are no circumstances
which are likely to lead to any application for rectification of the register of members. 

  
 57 

	15.	Insurance 

 The Disclosure Letter contains a copy of all insurance policies held by each
Group Company. In respect of such insurances: 
  

	 	(a)	all premiums have been duly paid to date; 

  

	 	(b)	so far as the Warrantor is aware all the policies are in full force and effect and are not voidable on account of any act, omission or nondisclosure on the part of the insured party nor so far as the Warrantor is aware
are they likely to be declared null and void as a consequence of which any claim might be rejected; and 

  

	 	(c)	so far as the Warrantor is aware there are no circumstances which will or are likely to give rise to any claim and no insurance claim is outstanding. 

 

	16.	Group structure 

 Save for each Subsidiary, the Company does not have any subsidiary
companies nor has it at any time been the holding company of any company or a member of or the beneficial owner of any shares, securities or other interest in any company or other person. 

 

	17.	Agreements and capital commitments 

  

	17.1	Each Group Company: 

  

	 	(a)	is not party to any agreement or arrangement which entitles any person to claim a fee or commission as a result of or in relation to Completion; 

 

	 	(b)	has no material capital commitments of a value greater than £100,000; 

  

	 	(c)	is not a party to any contract, arrangement or commitment (whether in respect of capital expenditure or otherwise) which is of an unusual, onerous or long-term nature (meaning not capable of termination
within a period of 12 months) or which involves or could involve a material obligation or liability; 

  

	 	(d)	has not become bound and no person has become entitled (or with the giving of notice and/or the issue of a certificate and/or the passage of time or otherwise may become entitled) to require it to repay any loan capital
or other debenture, redeemable preference share capital, borrowed money or grant made to it by any governmental or other authority or person prior to the stipulated duo date; 

 

	 	(e)	is not a party to any agreement which is or may become terminable as a result of die entry into or completion of this Agreement; 

  
 58 

	 	(f)	is not bound by any guarantee or contract of indemnity or suretyship under which any liability or contingent liability is outstanding; 

 

	 	(g)	has not entered into any agreement which requires or may require, or confers any right to require, the sale (whether for cash or otherwise) or the transfer by it of any material asset; 

 

	 	(h)	is not a party to any joint venture, consortium, partnership, unincorporated association or profit sharing arrangement or agreement; 

 

	 	(i)	so far as the Warrantor is aware, is not a party to any agreement requiring registration or notification under or by virtue of any statute; or 

 

	 	(j)	is not in material default of any material agreement or legally binding arrangement to which it is a party, and such Group Company is not aware of any material default of any such agreement or arrangement by any
counterparty to such agreement. 

  

	17.2	No Group Company has been or is a party to any contract or arrangements binding upon it for the purchase or sale of property or the supply of goods or services at a price different to that reasonably obtainable on an
arm’s length basis. 

  

	18.	Borrowings and facilities 

 Full details of all limits on each Group Company’s bank
overdraft facilities and all borrowings of each Group Company (including borrowing among the Group Companies) are set out in the Disclosure Letter and each Group Company is not in breach of any of their terms and so far as the Warrantor is aware
none of such facilities or terms of borrowing will be terminated as a result of die entry into of this Agreement. 
  

	19.	Social obligations 

  

	19.1	So far as the Warrantor is aware, each Group Company has during the three years ending on the date of this Agreement complied with all its Social Obligations. 

 

	19.2	No person has in the last 12 months notified any Group Company of any alleged breach of its Social Obligations and there are no disputes between any Group Company and its employees or any trade union. 

 

	20.	Additional Warranties 

  

	20.1	All board and shareholder approvals required by law were properly given for any corporate actions undertaken by the Company requiring such approval since its incorporation. 

 

	20.2	The Company owns the entire issued share capital of each Subsidiary and no other person has any interest in, rights over, or right to acquire any interest in, rights over, any shares in any Subsidiary.

  
 59 

	20.3	The Company is not a party to any agreement or arrangement which entitles any person to claim a fee or commission as a result of or in relation to the issue of shares or securities in the Company or the grant of any
right to subscribe for, or acquire any interest in, any shares or securities in the Company. 

  

	20.4	So far as the Warrantor is aware, all outstanding options granted to option holders resident in the UK pursuant to the Share Option Plan qualify for tax relief under Chapter 9 Part 7 PTETA and Schedule 5 ITEPA.

  

	20.5	In relation to all agreements for the licence of information technology to each Group Company: 

  

	 	(a)	such Group Company has satisfied all of its payment obligations which have fallen due for payment; and 

  

	 	(b)	such Group Company has not received notice that any of its operations constitute a material breach of any of these agreements and nor is it aware of any facts, matters or circumstances which are likely to give rise to
such an allegation of material breach. 

  

	20.6	Mo Group Company has received from any customer of such Group Company that has 1,000 seats or more notice to terminate its agreement with such Group Company or, as far as the Warrantor is aware, no such customer is
threatening to terminate its agreement with any Group Company and all agreements with such customers are in full force and effect against the Company and, so far as the Warrantor is aware, all agreements with such customers are in full force and
effect against such customers. 

  
 60 

 Schedule 6 

Part 1: Matters requiring Investor Majority consent 
  

	(a)	purchase, buy-in, redeem or reduce (other than pursuant to an existing agreement with a director, employee or consultant of any Group Company which has been disclosed to the Investors) share capital or consolidate or
sub-divide share capital; 

  

	(b)	propose or pay any dividend or propose or make any other distribution (as defined under section 1000 or section 1064 of CTA); 

  

	(c)	increase or decrease the maximum or minimum number of directors of the Company set out in the New Articles; 

  

	(d)	permit any Group Company to cease to carry on its business or permit any Group Company or its directors (or any one of them) to take any step to wind up any Group Company, save where it is insolvent (within the meaning
of section 123 of the Insolvency Act 1986); 

  

	(e)	permit any Group Company or its directors (or any one of them) to take any step to place any Group Company into administration (whether by the filing of an administration application, a notice of intention to appoint an
administrator or a notice of appointment), permit any Group Company or its directors to enter into any arrangement, scheme, moratorium, compromise or composition with its creditors (whether under Part I of the Insolvency Act 1986 or otherwise) or to
apply for an interim order under Part 1 of the Insolvency Act 1986, or permit any Group Company or its directors to invite the appointment of a receiver or administrative receiver over all or any part of the Group Company’s assets or
undertaking; 

  

	(f)	negotiate or permit the disposal of shares in the Company amounting to a Share Sale or IPO or negotiate or permit a Disposal; 

  

	(g)	permit any amendment to the New Articles (as adopted on or around the Completion Date) or the passing of any resolution which is inconsistent with the New Articles (as adopted on or around the Completion Date);

  

	(h)	make any material change to the nature of the business as carried on by any Group Company; 

  

	(i)	grant options to directors, employees and consultants of any Group Company in excess of the aggregate number set out in clause 7 or amend the Share Option Plan or adopt any new share option plan; 

 

	(j)	make any change to: 

  

	 	(i)	its auditors; or 

  

	 	(ii)	its accounting reference date; 

  
 61 

	(k)	other than where expressly contemplated by this Agreement or the Service Agreements, enter into or vary any transaction or arrangement with, or for the benefit of any directors or shareholders of the Company or any
other person who is a “connected person” with any of its directors or shareholders; or 

  

	(l)	enter into any transaction or make any payment other than on an arm’s length terms for the benefit of the Company. 

Part 2: Matters requiring Series A Majority 
  

	(a)	alter or change the rights, preferences or privileges attaching to the Series A Preferred Shares; 

  

	(b)	create any new class or series of shares in the capital of the Company having rights, preferences or privileges senior to or on a parity with the Series A Preferred Shares; 

 

	(c)	permit any amendment to the New Articles (as adopted on or around die Completion Date) or the passing of any resolution which is inconsistent with the New Articles (as adopted on or around the Completion Date);

  

	(d)	offer or grant any registration rights to any shareholder or potential shareholder in the Company that is senior to the registration rights as set out in the Registration Rights Agreement; 

 

	(e)	convert or cause or permit to be converted the whole or any part of any debt of any Group Company which is in existence on the Completion Date (including but not limited to the Existing Loan Notes) into Shares; or

  

	(f)	save as provided in clause 8, permit the removal of the Index Director. 

 Part 3:
Matters requiring Series B Majority 
  

	(a)	alter or change the rights, preferences or privileges attaching to the Series B Preferred Shares; 

  

	(b)	create any new class or series of shares in the capital of the Company having rights, preferences or privileges senior to or on a parity with the Series B Preferred Shares; 

 

	(c)	permit any amendment to the New Articles (as adopted on or around the Completion Date) or the passing of any resolution which is inconsistent with the New Articles (as adopted on or around the Completion Date);

  

	(d)	offer or grant any registration rights to any shareholder or potential shareholder in the Company that is senior to the registration rights as set out in die Registration Rights Agreement; 

  
 62 

	(e)	convert or cause or permit to be converted the whole or any part of any debt of any Group Company which is in existence on the Completion Date (including but not limited to me Existing Loan Notes) into Shares; or

  

	(f)	save as provided in clause 8, permit the removal of the Insight Director. 

 Part 4:
Matters requiring Board Consent 
  

	(a)	factor any of its debts, borrow monies (other than by way of its facilities in place at the date of this Agreement), accept credit (other than normal trade credit) or enter into finance lease or hire purchase
arrangements of an aggregate value in excess of £1,000,000; 

  

	(b)	mortgage or charge or permit the creation of or suffer to subsist any mortgage or fixed or floating charge, lien (other than a lien arising by operation of law) or other Encumbrance over the whole or any part of its
undertaking, property or assets (other than any mortgages and charges detailed in Schedule 2); 

  

	(c)	subscribe or otherwise acquire, or dispose of, any shares in the capital of any other company in a transaction or series of related transactions valued at more than £2,000,000; 

 

	(d)	acquire or dispose of the whole or part of the undertaking of any other person or dispose of the whole or part of the undertaking of the Company in each case in a transaction or series of related transactions valued at
more than £2,000,000; 

  

	(e)	deal in any way (including the acquisition or disposal, whether outright or by way of licence or otherwise howsoever) with intellectual property of the Company other than in the ordinary course of business; or

  

	(f)	incur any capital expenditure (including obligations under hire-purchase and leasing arrangements) which exceeds £200,000, except to die extent that such expenditure has been specifically provided for in a budget
approved by the Board; 

  

	(g)	dispose of any asset of a capital nature having a book or market value greater than £200,000; 

  

	(h)	establish any new branch, agency, trading establishment or business or close any such branch, agency, trading establishment or business; 

 

	(i)	make any change to: 

  

	 	(i)	its bankers or the terms of the mandate given to such bankers in relation to its accounts); or 

  

	 	(ii)	any budget approved by the Board; engage any employee or consultant on terms that either his contract cannot be terminated by three months’ notice or less or his basic salary is at the rate of
£160,000 per annum or more or increase basic salary of any employee or consultant to more than £160,000 per annum or vary the terms of employment of any employee earning (or so that after such variation he will) a basic salary
of more than £160,000 per annum; 

  
 63 

	(k)	vary or make any binding decisions on the terms of employment and service of any director or company secretary of the Company, increase or vary the salary or other benefits of any such officer, or appoint or dismiss any
such officer; 

  

	(l)	make any loan or advance or give any credit (other than in the ordinary course of business) to any person or acquire any loan capital of any corporate body (wherever incorporated); 

 

	(m)	conduct any litigation material to the Company, save for the collection of debts arising in the ordinary course of the business carried on by die Company or any application for an interim injunction or other application
or action (including interim defence) which is urgently required in the best interests of the Company in circumstances in which it is not reasonably practicable to obtain prior consent as aforesaid; 

 

	(n)	propose or implement any material variation to the Company’s pension scheme or any of the benefits payable to members of the scheme; 

 

	(o)	take or agree to take any leasehold interest in or licence over any real property with an annual lease or licence amount of more than £250,000; 

 

	(p)	other than where expressly contemplated by this Agreement or the entry into or variation of contracts of employment (including the Service Agreements), enter into or vary any transaction or arrangement with, or for the
benefit of any of its directors or shareholders or any other person who is a “connected person” with any of its directors or shareholders; 

  

	(q)	enter into any material partnership, joint venture or consortium agreement; 

  

	(r)	enter into or vary either any materially onerous contract or any other material or major or long term contract (other than in the ordinary course of business); or 

 

	(s)	make any gifts or charitable donations above £25,000 in aggregate per annum. 

Part 5: Matters requiring Founder Consent 
  

	(a)	purchase, buy-in, redeem or reduce (other than pursuant to an existing agreement with a director, employee or consultant of any Group Company which has been disclosed to the Investors) share capital or consolidate or
sub-divide share capital; 

  

	(b)	propose or pay any dividend or propose or make any other distribution (as defined under sections section 1000 or section 1064 of CTA); 

 

	(c)	increase or decrease the maximum or minimum number of directors of the Company set out in the New Articles; 

  
 64 

	(d)	permit any Group Company to cease to carry on its business or permit any Group Company or its directors (or any one of them) to take any step to wind up any Group Company, save where it is insolvent (within the meaning
of section 123 of the Insolvency Act 1986); 

  

	(e)	permit any Group Company or its directors (or any one of them) to take any step to place any Group Company into administration (whether by the filing of an administration application, a notice of intention to appoint an
administrator or a notice of appointment), permit any Group Company or its directors to enter into any arrangement, scheme, moratorium, compromise or composition with its creditors (whether under Part I of the Insolvency Act 1986 or otherwise) or to
apply for an interim order under Part I of the Insolvency Act 1986, or permit any Group Company or its directors to invite the appointment of a receiver or administrative receiver over all or any part of any Group Company’s assets or
undertaking; 

  

	(f)	negotiate or permit the disposal of shares in the Company amounting to a Share Sale or IPO or negotiate or permit a Disposal; 

  

	(g)	offer or grant any registration rights to any shareholder or potential shareholder in the Company that is senior to the registration rights as set out in the Registration Rights Agreement; 

 

	(h)	permit any amendment to die New Articles (as adopted on or around the Completion Date) or the passing of any resolution which is inconsistent with the New Articles (as adopted on or around the Completion Date);

  

	(i)	make any material change to the nature of the business as carried on by any Group Company; 

  

	(j)	grant options to directors, employees and consultants of any Group Company in excess of the aggregate number set out in clause 7 or amend the Share Option Plan or adopt any new share option plan; 

 

	(k)	convert or cause or permit to be converted the whole or any part of any debt of any Group Company which is in existence on the Completion Date (including but not limited to the Existing Loan Notes) into Shares; or

  

	(l)	save as provided in clause 8 or otherwise in this Agreement, permit the removal of a Founder Director. 

  
 65 

 Schedule 7 

Undertakings 
  

	(a)	The Board shall be notified as soon as practicable (and in any event within 7 Business Days of receipt of a written offer) after an approach is made to the Company or the Founders by an investor interested in investing
in the Company or by a party interested in entering into a Share Sale or Disposal. 

  

	(b)	Each Group Company shall take all reasonable action to protect its intellectual property rights and/or other property and assets. 

  

	(c)	All new business opportunities relevant to any Group Company shall only be taken up through the Company or a wholly owned subsidiary. 

 

	(d)	The Company and, where applicable, each Group Company shall comply with the terms of this Agreement, the New Articles and the Service Agreements. 

 

	(e)	The Company shall comply with all applicable laws and regulations and maintain all required licences and consents and shall as soon as reasonably practicable notify the Investors if the Company loses any such licence or
consent The Founders shall, so far as it lies within their respective powers to do so, procure that as soon as reasonably practicable upon receiving notice so to do from the Investors, the Company convenes and holds at short notice a general meeting
of the Company at such place and’ time as the Investors shall reasonably determine at which any resolution required by the Investors shall be proposed. 

  

	(g)	The Board shall ensure that all decisions which are material to any Group Company shall be taken at a properly convened board meeting of the relevant Group Company and all material decisions which are material to the
Group as a whole shall be taken at a properly convened board meeting of the Company. 

  

	(h)	The Board shall not exercise any discretion pursuant to the Share Option Plan without first obtaining the approval of me remuneration committee. 

 

	 	(i)	Procure that each Group Company shall, at all times keep insured with a reputable insurance office: 

  

	 	(i)	all its assets against such risks and in the manner and to the extent as shall be approved at a properly convened board meeting of that company; 

 

	 	(ii)	itself in respect of any loss, loss of profits and other risks to an extent as shall be approved at a properly convened board meeting of that company, and (iii) (to the extent permitted by law) its directors against any
liability incurred by them in the lawful performance of their duties to the extent as shall be approved at a properly convened board meeting of that company. 

  
 66 

 Schedule 8 

The Properties 
 1. First Floor, 2-8 Balfe
Street and 34-45 Caledonian Road, London N1 (lease) 
  

			
	Landlord:	  	Land & Equity Holdings Limited.
		
	Tenant:	  	Mimecast Limited.
		
	Term:	  	10 years from 16 February 2008.
		
	Rent:	  	From 16 February 2008 until 15 February 2010 - £150,345 per annum;
		
		  	From 16 February 2010 until 15 February 2013 - £161,910 per annum; and
		
		  	From 16 February 2013 until the end of the term - such yearly sum as determined in accordance with the rent review (details given below),

 2. Second Floor Premises, 2-8 Balfe Sheet and 34-45 Caledonian Road, London N1 (lease) 

 

			
	Landlord:	  	Land & Equity Holdings Limited.
		
	Tenant:	  	Mimecast Limited.
		
	Term:	  	10 years from 6 June 2008.
		
	Rent:	  	From 9 June 2008 until 5 June 2010 - £87,750 per annum;
		
		  	From 6 June 2010 until 5 June 2013 - £94,500 per annum; and
		
		  	From 6 June 2013 until the end of the term - such yearly sum as determined in accordance with the rent review (details given below).

 3. Ground Floor and Basement Premises, 4-6 Balfe Street and 34-45 Caledonian Road, London N1 (lease) 

 

			
	Landlord:	  	Land & Equity Holdings Limited.
		
	Tenant:	  	Mimecast Limited.
		
	Term:	  	From 3 July 2009 until and including 15 February 2018.
		
	Rent:	  	There is an initial rent free period from 3 July 2009 to 4 January 2010.
		
		  	From 4 January 2010 until 2 April 2010 - £90,000 per annum;
		
		  	From 3 April 2010 until 2 July 2010 a peppercorn;
		
		  	From 3 July 2010 until IS February 2013 - £90,900 per annum; and From 16 February 2013 until the end of the term - such yearly sum as determined in accordance with the rent review (details given
below).

  
 67 

 4. Ground Floor and Basement Promises, 8-10 Balfe Street and 34-45 Caledonian Road, London N1 (lease) 

 

			
	Landlord:	  	Land & Equity Holdings Limited.
		
	Tenant:	  	Mimecast Limited.
		
	Term:	  	From 21 January 2010 until and including 15 February 2018.
		
	Rent:	  	There is an initial rent free period from 21nd January 2010 and 2nd
		
		  	May 2010 and a second rent free period from 31 August 2010 until 2nd November 2010.
		
		  	From 3rd May 2010 until 2nd August 2010 - £60,000 per annum, pro-rated.
		
		  	From 3rd November 2010 until 15th February 2013- £60,000 per annum.
		
		  	From 16 February 2013 until the end of the term - such yearly sum as determined in accordance with the rent review (details given below).

 5. Basement, ground, first and second floor Premises, 10 Balfe Street and 34-45 Caledonian Road, London N1 (lease) 

 

			
	Landlord:	  	Land &. Equity Holdings Limited.
		
	Tenant:	  	Mimecast Limited.
		
	Term:	  	From 14 July 2012 until and including 15 February 2018.
		
	Rent:	  	There is an initial rent free period from 14th July 2009 to 4 January 2010
		
		  	From 5th January 2010 until 15th February 2013 - £100,000 per annum.
		
		  	From 16 February 2013 until the end of the term - such yearly sum as determined in accordance with the rent review (details given below).

 6. Residential dwelling known as 260 Ice Wharf, 17 New Wharf Road, Kingscross, London N1 9RF (general tenancy agreement) 

 

			
	Landlord:	  	Jonathan M Aldin.
		
	Tenant:	  	Mimecast Services Limited,

  
 68 

			
	Term:	  	12 months from 23 March 2012 to and including 22 March 2013.
		
		  	At any time after a period of 4 months from the date of this agreement the Landlord or Tenant may give not less than two months’ written notice to terminate this agreement.
		
	Rent:	  	£1,954.98 per month.

 7. Third Floor Building #25 (Suite 303) Watch Factory Mill Complex 203 Crescent Street, Waltham, Massachusetts 

 

			
	Landlord:	  	Watch City Ventures MT LLC.
		
	Tenant:	  	Mimecast North America Inc.
		
	Term:	  	62 months from 26 October 2009, option to extend for a further 5 years subject to conditions.
		
	Monthly Base Rent:	  	CD-RCD $0.00
		
		  	RCD-2/28/11 $12,250.00
		
		  	3/12/11-End of Year Lease 1 $19,191.67
		
		  	Lease Year 2 $19,779.17
		
		  	Lease Year 3 $20,366.67
		
		  	Lease Year 4 $20,954.17
		
		  	Lease Year 5 through Termination $21,541.67

 8. Third Floor Building #25 (Suite 303) Watch Factory Mill Complex 203 Crescent Street, Waltham, Massachusetts (Additional
Premises for extended floor space; amendment to agreement) 
  

			
	Landlord:	  	Watch City Ventures MT LLC,
		
	Tenant:	  	Mimecast North America Inc.
		
	Term:	  	From July 23 2010 to Terminate in line with the main lease agreement.
		
	Monthly Base Rent	  	Additional Premises Commencement Date (APCD)- APRCD $0.00
		
		  	APRCD- End of $12,331.67
		
		  	Year Lease 1 Lease Year 2 $16,622.92
		
		  	Lease Year 3 $17,116.67
		
		  	Lease Year 4 $17,610.42
		
		  	Lease Year 5 through Termination $18,104.17

  
 69 

 9. Units 13 to 15 on the ground floor of Building B Upper Orayston Office (agreement of lease) 

 

			
	Landlord:	  	City Square Trading 522 (PTY) Limited.
		
	Tenant:	  	Mimecast South Africa (PTY) Limited.
		
	Term:	  	1 November 2008 to 31 October 2013
		
	 Rent and Service charge (combined and including VAT):
	  	From I November 2008 to 31 October 2009 - R86 636.60;
		
		  	From 1 November 2009 to 31 October 2010-R94 433.90;
		
		  	From I November 2010 to 31 October 2011 - R102 932.95;
		
		  	From 1 November 2011 to 31 October 2012-Rl 12 196.91;
		
		  	and From 1 November 2012 to 31 October 2013 - R122 294.64.
		
	Deposit:	  	R228 000.

 10. Units 16 to 18 on the first floor of Building B Upper Grayston Office (agreement of lease) 

 

			
	Landlord:	  	City Square Trading 522 (PTY) Limited.
		
	Tenant:	  	Mimecast South Africa (PTY) Limited.
		
	Term:	  	1 November 2010 to 31 October 2013 Rent and From 1 November 2010 to 31 October 2011 - R106 813.88; Service charge From 1 November 2011 to 31 October 2012-Rl 16 427.13; and (combined and From 1 November
2012 to 31 October 2013 -R126 905.58. including VAT):
		
	Deposit:	  	R93 696.39.

 11. Units 20 to 21 on the second floor of Building B Upper Grayson Office (agreement of lease) 

 

			
	Landlord:	  	City Square Trading 522 (PTY) Limited.
		
	Tenant:	  	Mimecast South Africa (PTY) Limited.
		
	Term:	  	1 December 2011 to 31 October 2013

  
 70 

			
	 Rent and Service charge (combined and including VAT):
	  	From 1 December 2011 to 31 January 2012 - RO; Service charge
		
		  	From I February 2012 to 31 October 2012-R72 872.87;
		
		  	From 1 November 2012 to 31 October 2013 - R79 431.43.
		
	Deposit:	  	No Deposit

 12. Block A, Upper Grayston Office- 4 Parking Bays (104, 105, 95 and 96) (memorandum of agreement of lease) 

 

			
	Landlord:	  	DAL Agency
		
	Tenant:	  	Mimecast South Africa (PTY) Limited.
		
	Term:	  	1 August 2010 to 2 week notice by lessor/lessee
		
	Rent	  	R500.0C per bay per month
		
	Deposit:	  	No Deposit

 13. Old Warehouse Building, Black River Park, Observatory 

 

			
	Landlord:	  	Black River Park Investments (PTY) Limited.
		
	Tenant:	  	Mimecast South Africa (PTY) Limited.
		
	Term:	  	1 September 2010 to 31 August2013.
		
	Rent:	  	Rental at R92 per m1 x 296 m2 (9% escalation in March each year)
		
		  	01.09.2010-31.08.2011 : = R 310 399.92 ex VAT
		
		  	01.09.2011 - 31.08.2012 : = R 338 270.51 ex VAT
		
		  	01.09.2012 - 31.08.2013 : = R 368 714.86 ex VAT

 14. 500 Howard Street, San Francisco, California 
  

			
	Landlord:	  	HKS Inc, a Texas Corporation
		
	Tenant:	  	Mimecast North America, Inc.
		
	Term:	  	11 Months from 1st May 2012-31st March 2013
		
	Rent:	  	$6,000 per month

  
 71 

 15. 3rd Floor The Pinnacle, Reading, Berkshire RGT 1NH 

 

			
	Head Landlord:	  	Aviva International Insurance Limited.
		
	Tenant:	  	Mimecast Service Limited
		
	Term:	  	16 August 2010 to 15 August 2015
		
	Rent:	  	£87,542.50
		
	Sub Landlord:	  	Mimecast Service Limited
		
	Sub Tenant:	  	Responsys Limited
		
	Term:	  	9 January 2012 to 15 May 2015
		
	Rent:	  	£84,778.00

 16. New London Offices at City Point 
  

					
	a.	  	First Demise of the 6th Floor of the budding known as CityPoint, One Ropemaker Street, London, EC2Y 9SS (lease) (approximately 30,000 square feet).
			
		  	Landlord:	  	Sand Services Company (No.2)
			
		  	Tenant:	  	Mimecast Services Limited.
			
		  	Guarantor:	  	Mimecast Limited
			
		  	Term:	  	From and including the date of completion of the lease up to and including 1 December 2019.
			
		  	Rent:	  	There is an initial rent free period of 25 months from 14 September 2012 provided as 10 months’ rent free and 30 months at half rent.
			
		  		  	Rent is payable in the amount of £32.50 per square foot
			
		  	Rent Review:	  	Yes on the fifth anniversary of the term commencement date. The review will be upwards only to the market rent on the basis of the usual assumptions and disregards.
		
	b.	  	Second Demise of the 61’1 Floor of the building known as CityPoint, One Ropemaker Street, London, EC2Y 9SS
(lease) (approximately 10,000 feet).
			
		  	Landlord:	  	Sand Services Company (No.2)
			
		  	Tenant:	  	Mimecast Services Limited.

  
 72 

					
		  	Guarantor:	  	Mimecast Limited
			
		  	Term:	  	Shall begin 28 months after the completion of the lease for the first demise or at such earlier time agreed by the parties and shall expire on the 1 December 2019.
			
		  	Rent:	  	From the term commencement date but a licence fee equivalent to rent, service charge, insurance etc from the earlier of:
			
		  		  	 •       two weeks (or three weeks if reinstatement works are required) from the date the
Tenant takes access;

			
		  		  	 •       the date of practical completion of the removal works; and

			
		  		  	 •       the commencement of the fitting out works.

		
		  	        Rent is payable in the amount of £32.50 per square foot.
			
		  	Rent Review:	  	Yes – on the same bastes as the First Demise unless the term is less than 5 years in which case the rent review provisions will not apply and will be removed from the engrossed lease.

  
 73 

 Schedule 9 

Deed of Adherence 
 THIS DEED is made the
[                    ] day of
[                    ] by [                    ]

 WHEREAS 
  

	(A)	By a [transfer]/[subscription for shares] dated [of even date herewith] [                    ] [(the
“Transferor”) transfer (“the Subscriber”) subscribed for] Preferred Shares/Ordinary Shares of [                ] each in the capital of Mimecast
Limited (the “Company”) (together the [“Transferred Shares”/Subscribed Shares”]). 

  

	(B)	This Deed is entered into in compliance with the terms of clause [                    ] of an agreement dated
[                    ] made between (1) [name parties to the agreement] and (2) the Company and others (all such terms as are therein
defined) (which agreement is herein referred to as the “Investment Agreement”). 

 NOW THEREFORE IT IS HEREBY AGREED as follows:

  

	1.	Words and expressions used in this Deed shall have the same meaning as is given to them in the Investment Agreement unless the context otherwise expressly requires. 

 

	2.	The [Transferee]/[Subscriber] hereby agrees to assume the benefit of the rights [of the Transferor] under the Investment Agreement in respect of the [Transferred]/[Subscribed] Shares) in respect of die
[Transferred]/[Subscribed] Shares. 

  

	3.	The [Transferee]/[Subscriber] hereby agrees to be bound by the Investment Agreement in all respects as if the [Transferred]/[Subscriber] were a party to the Investment Agreement as one of the [Investors and/or Founders
and/or Existing Shareholders] and to perform [: 

  

	 	(a)	all the obligations of the Transferor in that capacity thereunder; and 

  

	 	(b)	]all the obligations expressed to be imposed on such a party to the Investment Agreement[;] 

[in both cases], to be performed or on or after [the date hereof] 
  

	4.	This Deed is made for the benefit of: 

  

	 	(a)	the parties lo the Investment Agreement; and 

  

	 	(b)	any other person or persons who may after the date of the Investment Agreement (and whether or not prior to or after the date hereof) assume any rights or obligations under the Investment Agreement and be permitted to
do so by the terms thereof; and this Deed shall be irrevocable without the consent of the Company acting on their behalf in each case only for so long as they hold any Series A Preferred Shares/Series B Preferred Shares/Ordinary Shares in the
capital of the Company. 

  
 74 

	5.	[For the avoidance of doubt nothing in this Deed shall release the Transferor from any liability in respect of any obligations under the Investment Agreement due to be performed prior to[the date of this deed].]

  

	6.	None of the existing parries to the Investment Agreement: 

  

	 	(a)	makes any representation or warranty or assumes any responsibility with respect to the legality, validity, effectiveness, adequacy or enforceability of any of the Investment Agreement (or any agreement entered into
pursuant thereto); or 

  

	 	(b)	makes any representation or warranty or assumes any responsibility with respect to the content of any information regarding the Company or any member of the group or otherwise relates to the [acquisition]/[subscription]
of shares in the Company; or 

  

	 	(c)	assumes any responsibility for the financial condition of the Company [or any Subsidiary] or any other party to the Investment Agreement or any other document or for the performance and observance by the Company or any
other party of the Investment Agreement or any other document (save as expressly provided therein); and any and all conditions and warranties, whether express or implied by law or otherwise, are excluded save for the representations, warranties and
undertakings contained in the Warranties. 

  

	7.	This Agreement and any dispute or claim arising out of, or in connection with, it or its subject matter or formation (including any dispute or claim relating to non-contractual obligations) shall be governed by and
construed in accordance with English taw. 

 IN WITNESS WHEREOF this Deed of Adherence is executed as a deed on the date and year first above
written. 
 Executed as DEED by [Transferor/Subscriber] 

  
 75 

 Schedule 10 

Part 1: Terms of reference for Remuneration Committee 

(Adopted by the Board on 28 January 2010) 
  

	1.	The Remuneration Committee 

 The Remuneration Committee: 

 

	 	(a)	is a committee of the board and shall make recommendations to the board on general policy and determine on behalf of the board specific remuneration packages for each of the executive directors; 

 

	 	(b)	is composed of the non-executive directors with a quorum of two; 

  

	 	(c)	has a primary responsibility of reviewing remuneration, in its widest sense (see below) and ensuring that it is adequate for current employees as to suitably tie them into our Company and also of a sufficient level to
attract high caliber employees; and 

  

	 	(d)	will meet sufficiently frequently and for long enough to perform its duties effectively. 

  

	2.	Membership 

  

	2.1	There should be a minimum of 3 members. 

  

	2.2	The majority of members, apart from directors’ fees and shareholdings, should be independent of management and free from any involvement which might significantly interfere with their ability to judge matters
independently. 

  

	2.3	The Company Secretary shall be the committee secretary and proper minutes shall be kept of its proceedings which shall be circulated to all directors of the Company. 

 

	3.	Meetings 

  

	3.1	Remuneration Committee meetings shall be held not less than once a year. 

  

	3.2	Although not a member of the Remuneration Committee, on occasion and for matters not related to himself, the chief executive officer may be invited to attend meetings of the Remuneration Committee and, in any event,
shall be consulted by the Remuneration Committee on proposals relating to the remuneration of the other executive directors and of the senior executives of die group. 

  
 76 

	4.	Chairman 

 The members of the Remuneration Committee will elect one of the members of the
Remuneration Committee to act as Chairman of the Remuneration Committee. The first chairman will be Michael Hedger. The Chairman will be responsible for. 
  

	 	(a)	the preparation of the agenda; 

  

	 	(b)	the timely distribution of the agenda and any supporting papers; 

  

	 	(c)	reporting to the board on issues and decisions made; 

  

	 	(d)	briefing any consultants retained to provide independent advice on market practice (and for which advice a budget should be provided, when necessary). 

 

	5.	Remuneration 

 ‘Remuneration’ is not confined simply to salaries and bonuses.
It now has a wider definition and includes pension arrangements, share options, Share Save schemes, employees’ share ownership schemes (ESOP’s), Funded Unapproved Retirement Benefit Schemes (FURBS) and anything that is intended as
‘pay’ for any employee. It also includes fringe benefits e.g. Company cars, use of Company premises for living purposes and so on. Many of these matters will be covered in service agreements but the Remuneration Committee should determine
not only the Company’s overall policy but also appropriate individual cases. Policy will also involve the purpose of objective of remuneration. 
  

	6.	Authorisation 

  

	6.1	The Remuneration Committee shall be authorised to take such external advice as it shall consider appropriate to determine the remuneration, terms of service and incentives of the executive directors. 

 

	6.2	The Remuneration Committee shall have no authority in relation to the remuneration of the non-executive directors. 

  

	7.	Duties 

  

	7.1	The Remuneration Committee shall have regard to and shall comply with the Combined Code on corporate governance relating to remuneration committees or remuneration of directors, so far as practicable for a Company of
the size and nature as the Company, and shall also have regard to any authoritative best practice guidelines for remuneration committees published from time to time. 

 

	7.2	The Remuneration Committee shall: 

  

	 	(a)	review and determine on behalf of the board specific remuneration and incentive packages for each of the Company’s executive directors (including pension rights and any compensation payments) to ensure that the
executive directors are fairly rewarded for their individual contributions to the Company’s overall performance; the review of remuneration and incentive packages should be both on appointment and on each occasion that changes to those packages
are proposed; 

  
 77 

	 	(b)	keep under review the remuneration and all other benefits of all executive directors and senior executives and managers; 

  

	 	(c)	in determining the remuneration and incentive packages of individual executive directors, the Remuneration Committee should: 

  

	 	(i)	provide the packages needed to attract, retain and motivate executive directors of the quality required but should avoid paying more than is necessary for this purpose; 

 

	 	(ii)	judge where to position the Company relative to other companies, the Remuneration Committee should be aware of what comparable companies are paying and should take account of relative performance - but the Remuneration
Committee should use such comparisons with caution, in view of the risk that they can result in an upward ratchet of remuneration levels with no corresponding improvement in performance; 

 

	 	(iii)	be sensitive to the wider scene, including pay and employment conditions elsewhere in the group especially when determining annual salary increases; 

 

	 	(iv)	include performance-related elements of remuneration as a significant proportion of the total remuneration packages and those elements should be designed to align the interests of executive directors with those of
shareholders and give keen incentives to perform at the highest levels; and 

  

	 	(v)	in designing schemes of performance related remuneration, follow the provisions in Schedule A to the Combined Code on corporate governance, so far as practicable to the Company given its size and nature; make
recommendations from time to time to the board on the introduction, variation or discontinuance of all forms of reward to the same persons, whether in case or kind and on the Company’s framework of executive remuneration generally and its
cost, exercise the power to take advice from any person it may deem necessary to help the Remuneration Committee to achieve then-purpose and objectives; continually review, investigate, report upon and recommend as appropriate all forms of
reward that might be applicable including share options, pension schemes, ESOPs, FURBS and so on; operate and administer the Company’s share option and share incentive schemes in accordance with the respective rules thereof, the Remuneration
Committee shall make recommendations to the board as to any adjustments to the terms of such schemes and as to proposals intended for submission to shareholders in relation to such schemes; 

  
 78 

	 	(h)	review the design of remuneration structures, levels of pay, incentives and fringe benefits; 

  

	 	(i)	be responsible for reporting to the Company’s shareholders, on behalf of the board, in relation to remuneration policies applicable to the Company’s executive directors, drawing attention to factors specific
to the Company; in preparing or making any such report the Remuneration Committee shall follow the provisions set out in Schedule B to the Combined Code on corporate governance; 

 

	 	(j)	review procedures for the identification, training, remuneration and career development of all executives, senior and junior who aspire to and may be expected to hold the most senior posts with clear policies for their
encouragement; and 

  

	7.3	The Remuneration Committee shall also consider such other topics as are defined by the board from time to time. 

References in these terms of reference to “senior executives of the group” shall mean the Chief Executive Officer and his direct reports. 

  
 79 

 Part 2: Terms of reference for Audit Committee 

(Adopted by the Board on 28 January 2010) 
  

	1.	The Audit Committee 

 The Audit Committee: 

 

	 	(a)	is a committee of the board and shall make recommendations to the board which retains the right of final decision; 

  

	 	(b)	is composed of the non-executive directors with a quorum of two; 

  

	 	(c)	has die primary responsibility of reviewing the financial statements and the accounting principles and practice underlying them, liaising with the external and internal auditors and reviewing the effectiveness of
internal controls; and 

  

	 	(d)	will meet at least once a year but sufficiently frequently and for long enough to perform its duties effectively. 

  

	2.	Main role and responsibilities 

 The main role and responsibilities of the Audit
Committee are to: 
  

	 	(a)	monitor the integrity of the financial statements of the Company and any formal announcements relating to the Company’s financial performance, reviewing significant financial reporting judgements contained in them;

  

	 	(b)	review the Company’s internal financial controls and, unless expressly addressed by a separate board risk committee composed of independent directors or by the board itself, the Company’s internal control and
risk management systems; 

  

	 	(c)	monitor and review the effectiveness of the Company’s internal audit function; if applicable 

  

	 	(d)	make recommendations to the board, for it to put to the shareholders for their approval in general meeting, in relation to the appointment of the external auditor and to approve the remuneration and terms of engagement
of the external auditor; 

  

	 	(e)	review and monitor the external auditor’s independence and objectivity and the effectiveness of the audit process, taking into consideration relevant UK professional and regulatory requirements; 

 

	 	(f)	develop and implement policy on the engagement of the external auditor to supply non-audit services, taking into account relevant ethical guidance regarding the provision of non-audit services by the external audit
firm; and 

  

	 	(g)	report to the Board, identifying any matters in respect of which it considers that action or improvement is needed. 

  
 80 

	3.	Membership 

  

	3.1	There should be a minimum of 3 members. 

  

	3.2	The majority of members, apart from directors’ fees and shareholding, should be independent of management and free from any involvement which might significantly interfere with their ability to judge matters
independently. 

  

	3.3	The Company Secretary shall be the committee secretary and proper minutes shall be kept of its proceedings which shall be circulated to all directors of the Company, and, if the Audit Committee so chooses, to the
Company’s external auditor. 

  

	4.	Meetings 

  

	4.1	Audit Committee meetings shall be held not less than two limes a year, to discuss general audit matters, me annual report and statements. The external auditor may request a meeting if they consider that one is
necessary. 

  

	4.2	The external auditor, the chief financial officer and the financial controller of the Company should normally attend meetings of the Audit Committee without being members. 

 

	4.3	Other executive directors of the Company may attend meetings by invitation of the Audit Committee, without being members. 

  

	5.	Chairman 

 The members of the Audit Committee will be responsible for electing one of the
members of the Audit Committee to act as Chairman. The first chairman of the Audit Committee shall be Christopher FitzGerald. The Chairman will be responsible for 
  

	 	(a)	the preparation of the agenda; 

  

	 	(b)	the timely distribution of the agenda and any supporting papers; (c) reporting to the board on issues and decisions made; 

  

	6.	Authorisation 

  

	6.1	The Audit Committee is authorised by die board to investigate any activity within its terms of reference. It is authorised to seek any information it requires from any employee and all employees will be directed by the
board to co-operate with any request made by the Audit Committee. 

  

	6.2	The Audit Committee is authorised by the board to obtain outside legal or other independent professional advice and to secure the attendance of outsiders with relevant experience and expertise if it considers this
necessary. This authority is subject only to the requirement that independent advice is sought at a reasonable cost commensurate with the matter under review. 

  
 81 

	7.	Duties 

 The duties of the Audit Committee shall be as follows. 

 

	7.1	External reporting 

  

	 	(a)	Review the interim and final financial statements before submission to the board, focusing particularly on: 

  

	 	(i)	any change in accounting policies and practices; 

  

	 	(ii)	any major judgemental areas; 

  

	 	(iii)	any significant adjustments resulting from the audit; 

  

	 	(iv)	the going concern assumption; 

  

	 	(v)	compliance with accounting standards; 

  

	 	(vi)	compliance with applicable regulatory and legal requirements; and 

  

	 	(vii)	compliance with best practice in the area of corporate governance. 

  

	 	(b)	Review the annual report in its entirety. 

  

	 	(c)	Review me summary financial reports. 

  

	 	(d)	Review circulars issued in respect of takeovers, defences against takeovers and other major non-routine transactions. 

  

	 	(e)	Review press statements and advertisements relating to financial matters prior to their issue. 

  

	7.2	External auditor 

  

	 	(a)	Consider die appointment of the external auditor and any questions of resignation or dismissal. 

  

	 	(b)	Review the proposed audit fee and keep under review the scope and results of the audit and its cost effectiveness. 

  

	 	(c)	Prior to the audit commencing, discuss the nature, scope and timing with the external auditor and ensure co-ordination where more than one audit firm is involved. 

 

	 	(d)	Discuss any problems and reservations arising with the interim and final accounts audits and any matters the auditor may wish to raise. 

 

	 	(e)	Discuss the meaning and significance of audited figures and any notes thereto. 

  
 82 

	 	(f)	Review the external auditors’ evaluation of the Company’s internal controls, the management letter and the management’s response. 

 

	 	(g)	Review any factors that might impair, or be perceived to impair, the external auditor’s independence and objectivity. Where the auditor also supplies a substantial volume of non-audit services to the Company, keep
the nature and extent of such services under review, seeking to balance the maintenance of objectivity and value for money. 

  

	 	(h)	Arbitrate in any disputes between the auditors and management. 

  

	 	(i)	Consider periodically an assessment by the external auditor of the quality of accounting and finance personnel in the group. 

  

	7.3	Other matters 

  

	 	(a)	Enquire into illegal, questionable or unethical activities. 

  

	 	(b)	Adherence of officials to the corporate code of conduct. 

  

	 	(c)	Review any significant transactions outside the Company’s normal business. 

  

	 	(d)	Initiate special projects or investigations on any matter within its term of reference. 

  

	 	(c)	Review the efforts of the Company to comply with social and environmental obligations. 

  

	 	(f)	Ensure that the board, and especially the non-executive directors, receive timely relevant and reliable information, tailored to assist them with monitoring the business and taking important decisions.

  

	 	(g)	Consider from time to time appointing a “risk sub-committee” and (with any risk sub-committee) to keep abreast of all changes made to the group’s system of internal controls and to follow up on areas
which require improvement. 

  

	 	(h)	Consider other topics as defined by the board front time to time. 

  
 83 

 Schedule 11 

Agreed Form Documents 
  

	1.	Accounts 

  

	2.	Board and shareholder resolutions of the Company 

  

	3.	Disclosure Letter 

  

	4.	Employee Information Table 

  

	5.	Existing Loan Note Schedule 

  

	6.	Management Accounts 

  

	7.	Management Rights Letter 

  

	8.	New Articles 

  

	9.	Registration Rights Agreement 

  

	10.	Director Indemnification Agreements 

  

	11.	Cash Offer (including Acceptance and Authority) 

  
 84 

 APPENDIX 

Pre-Completion Capitalisation Table 

  
 85 

 ATTESTATIONS 
  

					
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INSIGHT VENTURE PARTNERS VII, L.P.	 	)	 	
	By: its General Partner	 	)	 	
	Insight Venture Associates VII, L.P.	 	)	 	/s/ illegible
	By: its General Partner	 	)	 	  

	Insight Venture Associates VII, Ltd.	 	)	 	Director / Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INSIGHT VENTURE PARTNERS (CAYMAN)	 	)	 	
	VII, L.P.	 	)	 	
	By: its General Partner	 	)	 	
	Insight Venture Associates VII, L.P.	 	)	 	/s/ illegible
	By: its General Partner	 	)	 	  

	Insight Venture Associates VII, Ltd.	 	)	 	Director / Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INSIGHT VENTURE PARTNERS VII	 	)	 	
	(CO-INVESTORS), L.P.	 	)	 	
	By: its General Parmer	 	)	 	
	Insight Venture Associates VII, L.P.	 	)	 	/s/ illegible
	By: its General Partner	 	)	 	  

	Insight Venture Associates VII, Ltd.	 	)	 	Director / Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INSIGHT VENTURE PARTNERS	 	)	 	
	(DELAWARE) VII, L.P.	 	)	 	
	By: its General Parmer	 	)	 	
	Insight Venture Associates VII, L.P.	 	)	 	/s/ illegible
	By: its General Partner	 	)	 	  

	Insight Venture Associates VII, Ltd.	 	)	 	Director / Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INSIGHT VENTURE PARTNERS	 	)	 	
	COINVESTMENT FUND II, LL.P.	 	)	 	
	By: its General Partner	 	)	 	
	Insight Venture Associates Coinvestment II, L.P.	 	)	 	/s/ illegible
	By: its General Partner	 	)	 	  

	Insight Holdings Group, LLC	 	)	 	Director / Authorised Signatory

  
 86 

					
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INDEX VENTURES V (JERSEY), L.P.	 	)	 	/s/ Paul Willing
	By: its Managing General Partner:	 	)	 	  

	Index Venture Associates V Limited	 	)	 	Director / Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by INDEX VENTURES V PARALLEL	 	)	 	
	ENTREPRENEUR FUND (JERSEY), L.P.	 	)	 	/s/ Paul Willing
	By: its Managing General Partner:	 	)	 	  

	Index Venture Associates V Limited	 	)	 	Director / Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	
	by YUCCA PARTNERS LP JERSEY	 	)	 	
	BRANCH	 	)	 	
	By: Ogier Employee Benefit	 	)	 	
	Services Limited in its capacity as administrator	 	)	 	/s/ illegible
	of the Index Co-Investment Scheme as	 	)	 	  

	Authorised Signatory of Yucca Partners LP	 	)	 	Director / Authorised Signatory
		 	)	 	Employee Benefit
		 	)	 	Services Limited
			
	EXECUTED and DELIVERED as a DEED	 	)	 	 /s/ Norman Fiore

	By DAWN ENTERPRISE CAPITAL	 	)	 	Authorised Signatory
	FUND LP acting by its general partner	 	)	 	
	DAWN CAPITAL LLP	 	)	 	/s/ Haakon Overli
		 	)	 	  

		 	)	 	Authorised Signatory
			
	EXECUTED and DELIVERED as a DEED	 	)	 	 /s/ Vincent McCartney

	By DAWN MIMECAST	 	)	 	Director
	HOLDINGS LIMITED	 	)	 	
		 	)	 	/s/ Karen Bell
		 	)	 	  

		 	)	 	Director/Secretary

  
 87 

							
	EXECUTED and DELIVERED as a DEED	 	)	 	 /s/ Vincent McCartney

	By DAWN MIMECAST	 	)	 	Director
	(II) HOLDINGS LIMITED	 	)	 	
		 		 	)	 	/s/ Karen Bell
		 		 	)	 	  

		 		 	)	 	Director/Secretary
			
	EXECUTED and DELIVERED as a DEED	 	)	 	 /s/ illegible

	By OSPREY HEIGHTS LIMITED	 	)	 	Director
		 		 	)	 	
		 		 	)	 	
		 		 	)	 	  

		 		 	)	 	Director/Secretary
			
	SIGNED as a DEED and DELIVERED	 	)	 	/s/ Peter Bauer
	by PETER BAUER in the	 	)	 	  

	witness signature	 	 /s/ Mark Bilbe
	 	)	 	
	witness name 	 	Mark Bilbe	 		 	
	witness address	 	  
	 		 	
	witness occupation	 	General Manager, Mimecast USA	 		 	
			
	SIGNED as a DEED and DELIVERED	 	)	 	/s/ Neil Murray
	by NEIL MURRAY in the	 	)	 	  

	witness signature	 	 /s/ Peter Campbell
	 	)	 	
	witness name 	 	Peter Campbell	 		 	
	witness address	 	  
	 		 	
	witness occupation	 	Chartered Accountant	 		 	

  
 88 

							
	EXECUTED and DELIVERED as a DEED	 	)	 	
	By BUTTERWORTH TRUST	 	)	 	
				
		 		 	)	 	/s/ Graeme Harker
		 		 		 	  

		 		 		 	Trustee
				
		 		 	)	 	
		 		 		 	  

		 		 	)	 	Trustee
			
	SIGNED as a DEED and DELIVERED	 		 	/s/ Roger Fullerton
	by ROGER FULLERTON in the	 	)	 	  

	presence of:	 	)	 	
	witness signature 	 	 /s/ Isabel Gordon-Szabo
	 		 	
	witness name	 	Isabel Gordon-Szabo	 		 	
	witness address	 	  
	 		 	
	witness occupation	 	Hair Stylist	 		 	
			
	 SIGNED as a DEED and DELIVERED
	 	)	 	/s/ James Espey
	by JAMES ESPEY in the	 	)	 	  

	presence of:	 	)	 	
	witness signature 	 	 /s/ Catarina Montero
	 		 	
	witness name	 	Catarina Montero	 		 	
	witness address	 	  
	 		 	
	witness occupation	 	Marketing Manager	 		 	
			
	SIGNED as a DEED and DELIVERED	 	)	 	/s/ Mark Bilbe
	by MARK BILBE in the	 	)	 	  

	presence of:	 	)	 	
	witness signature	 	 /s/ Hylton Southey
	 		 	
	witness name	 	Hylton Southey	 		 	
	witness address	 	  
	 		 	
	witness occupation	 	Sales	 		 	
			
	EXECUTED and DELIVERED as a DEED	 	)	 	 /s/ CF FitzGerald

	By MIMECAST LIMITED	 	)	 	Director
		 		 	)	 	
		 		 	)	 	 /s/ Peter Campbell

		 		 	)	 	Director/Secretary

  
 89EX-4.3

 Exhibit 4.3 

REGISTRATION RIGHTS AGREEMENT 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	1.	  	 Definitions
	  	 	1	  
			
	2.	  	 Registration Rights
	  	 	4	  
			
		  	 2.1        Demand Registration
	  	 	4	  
			
		  	 2.2        Company Registration
	  	 	6	  
			
		  	 2.3        Underwriting Requirements
	  	 	6	  
			
		  	 2.4        Obligations of the Company
	  	 	7	  
			
		  	 2.5        Furnish Information
	  	 	9	  
			
		  	 2.6        Expenses of Registration
	  	 	9	  
			
		  	 2.7        Delay of Registration
	  	 	9	  
			
		  	 2.8        Indemnification
	  	 	9	  
			
		  	 2.9        Reports Under Exchange Act
	  	 	11	  
			
		  	 2.10      Limitations on Subsequent Registration Rights
	  	 	12	  
			
		  	 2.11      “Market Stand-off’ Agreement
	  	 	12	  
			
		  	 2.12      Restrictions on Transfer
	  	 	13	  
			
		  	 2.13      Termination of Registration Rights
	  	 	14	  
			
		  	 2.14      Required Registration
	  	 	14	  
			
	3.	  	Miscellaneous	  	 	14	  
			
		  	 3.1        Successors and Assigns
	  	 	14	  
			
		  	 3.2        Governing Law
	  	 	15	  
			
		  	 3.3        Counterparts
	  	 	15	  
			
		  	 3.4        Titles and Subtitles
	  	 	15	  
			
		  	 3.5        Notices
	  	 	15	  
			
		  	 3.6        Amendments and Waivers
	  	 	15	  
			
		  	 3.7        Severability
	  	 	16	  
			
		  	 3.8        Aggregation of Stock
	  	 	16	  
			
		  	 3.9        Entire Agreement
	  	 	16	  
			
		  	 3.10      Dispute Resolution
	  	 	16	  
			
		  	 3.11      Delays or Omissions
	  	 	17	  
			
		  	Schedule A - Schedule of Investors	  			

  
 i 

 Exhibit 4.3 

REGISTRATION RIGHTS AGREEMENT 

THIS REGISTRATION RIGHTS AGREEMENT is made as of the 18th day of September, 2012 (this
“Agreement”), by and among Mimecast Limited (company number 04698693), a company incorporated in England and Wales (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred
to in this Agreement as an “Investor.” 
 RECITALS 

WHEREAS, the Company and certain of the Investors are parties to the Subscription and Shareholders’ Agreement of even date
herewith (the “Purchase Agreement”); and 
 WHEREAS, in order to induce the Company to enter into the Purchase
Agreement and to induce certain of the Investors to invest funds in the Company pursuant to the Purchase Agreement, the Investors and the Company hereby agree that this Agreement shall govern the rights of the Investors to cause the Company to
register A Ordinary Shares issuable to the Investors and shall govern certain other matters as set forth in this Agreement. 
 NOW,
THEREFORE, the parties hereby agree as follows: 
 1. Definitions. For purposes of this Agreement: 

1.1 “A Ordinary Shares” means A ordinary shares of £0.00001 each in the capital of the Company, having the rights set
out in the Articles. 
 1.2 “Affiliate” means, with respect to any specified Person, any other Person who, directly or
indirectly, controls, is controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that is
controlled by one or more general partners or managing members of, or shares the same management or advisory company with, such Person. 

1.3 “Articles” means the Articles of Association of the Company as in force from time to lime. 

1.4 “Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under
the Securities Act, the Exchange Act, or other federal or state law in the United States, insofar as such loss, damage, claim or liability (or any action in respect thereof) arises out of or is based upon (i) any untrue statement or alleged
untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; (ii) an omission or alleged
omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or (iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of
the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any state securities law in the United States, 

 1.5 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder. 
 1.6 “Excluded Registration” means (i) a registration relating to
the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; or (iii) a registration in which the only A
Ordinary Shares being registered are A Ordinary Shares issuable upon conversion of debt securities that are also being registered. 
 1.7
“Family Trust” means as regards any particular individual Holder (or deceased or former individual Holder) trusts (whether arising under a settlement, declaration of trust or other instrument by whomsoever or wheresoever made, or
under a testamentary disposition or on an intestacy) under which no immediate beneficial interest in any of the Registrable Securities in question is for the time being vested in any Person other than the particular Holder and/or any of the
Privileged Relations of that Holder (and so that for this purpose a Person shall be considered to be beneficially interested in a share if such share or the income thereof is liable to be transferred or paid or applied or appointed to or for the
benefit of any such Person or any voting or other rights attaching thereto are exercisable by or as directed by any such Person pursuant to the terms of the relevant trusts or in consequence of an exercise of a power or discretion conferred thereby
on any Person or Persons). 
 1.8 “Founder Shares” means the founder ordinary shares of £0.00001 each in the capital
of the Company, having the rights set out in the Articles. 
 1.9 “Holder” means any holder of Registrable Securities who
is a party to this Agreement. 
 1.10 “Initiating Holders” means, collectively, Holders who properly initiate a
registration request under this Agreement. 
 1.11 “IPO” means the Company’s first underwritten public offering in the
United States of its A Ordinary Shares under the Securities Act. 
 1.12 “Person” means any individual, corporation,
partnership, trust, limited liability company, association or other entity. 
 1.13 “Preferred Holders” means the Series A
Holders and the Series B Holders. 
 1.14 “Privileged Relation” means in relation to a Holder who is an individual Holder
(or a deceased or former individual Holder) means a spouse, civil partner (as defined in the Civil Partnerships Act 2004), child or grandchild (including step or adopted or illegitimate child and their issue). 

1.15 “Registrable Securities” means (i) the A Ordinary Shares into which the Founder Shares, Series A Preferred Shares
or Series B Preferred Shares have converted or may convert from time to time pursuant to the Articles; (ii) any A Ordinary Shares, or any A Ordinary Shares arising upon conversion and/or exercise of any other securities of the Company, held by

  
 2 

 
the Investors as of the date hereof or acquired by the Investors after the date hereof; and (iii) any A Ordinary Shares issued as (or arising upon the conversion or exercise of any warrant,
right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses (i) and (ii) above; excluding in all cases, however, any Registrable
Securities sold by a Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant to Subsection 3.1, and excluding for purposes of Section 2 any shares for which registration rights have
terminated pursuant to Subsection 2.13 of this Agreement. 
 1.16 “Registrable Securities then outstanding” means
the number of shares determined by adding the number of A Ordinary Shares that are Registrable Securities and the number of A Ordinary Shares (directly or indirectly) which may be issued or which otherwise may arise pursuant to the exercise of,
and/or conversion of, convertible securities that are Registrable Securities. 
 1.17 “Restricted Securities” means the
securities of the Company required to bear the legend set forth in Subsection 2.12 hereof. 
 1.18 “SEC” means the
United States Securities and Exchange Commission. 
 1.19 “SEC Rule 144” means Rule 144 promulgated by the SEC under the
Securities Act. 
 1.20 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act. 

1.21 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 1.22 “Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable to
the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in Subsection 2.6. 

1.23 “Series A Holders” means holders of Series A Preferred Shares (or any Ordinary Shares into which such Series A Preferred
Shares have been converted). 
 1.24 “Series B Holders” means holders of Series B Preferred Shares (or any Ordinary Shares
into which such Series B Preferred Shares have been converted). 
 1.25 “Series A Preferred Shares” means the convertible
series A preferred shares of £0,00001 each in the capital of the Company, having the rights set out in the Articles. 
 1.26
“Series B Preferred Shares” means the convertible series B preferred shares of £0.00001 each in the capital of the Company, having the rights set out in the Articles. 

1.27 “SSA” means the Subscription and Shareholders’ Agreement, dated as of the date hereof, among the Company, the
Founders (as defined therein), the Preferred Holders and certain other shareholders of the Company (as amended, modified, supplemented or restated from time to time). 

  
 3 

 2. Registration Rights. The Company covenants and agrees as follows: 

2.1 Demand Registration. 

(a) Form S-l/Form F-1 Demand. If at any time after one hundred eighty (180) days after the effective date of the registration
statement for the IPO, the Company receives a request from (1) the Series A Holders holding at least a majority of the Registrable Securities then-held by all Series A Holders that the Company file a Form S-l or Form F-1 registration statement
(or any applicable successor registration form under the Securities Act subsequently adopted by the SEC), (2) the Series B Holders holding at least a majority of the Registrable Securities then-held by all Series B Holders that the Company file
a Form S-l or Form F-1 registration statement (or any applicable successor registration form under the Securities Act subsequently adopted by the SEC), or (3) the holders of Founder Shares holding at least a majority of the Registrable
Securities then-held by all holders of Founder Shares that the Company file a Form S-l or Form F-1 registration statement (or any applicable successor registration form under the Securities Act subsequently adopted by the SEC), then the Company
shall (i) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”) to all Holders other than the Initiating Holders; and (ii) as soon as reasonably practicable, and in any event
within sixty (60) days after the date such request is given by the Initiating Holders, file such registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any
additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each
case, subject to the limitations of Subsection 2.1(c) and Subsection 2.3. 
 (b) Form S-3/Form F-3 Demand. If at any
time when it is eligible to use a Form S-3 or Form F-3 registration statement (or any registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents
filed by the Company with the SEC), the Company receives a request from (1) the Series A Holders holding at least ten percent (10%) of the Registrable Securities then-held by all Series A Holders, (2) the Series B Holders holding at
least ten percent (10%) of the Registrable Securities then-held by all Series B Holders, or (3) the holders of Founder Shares holding at least ten percent (10%) of the Registrable Shares then-held by all holders of Founder Shares, in
each case, that the Company file such registration statement with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses, of at least $5 million, then the Company shall
(i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other than the Initiating Holders; and (ii) as soon as reasonably practicable, and in any event within forty-five (45) days
after the date such request is given by the Initiating Holders, file such registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be included in such registration and any
additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each
case, subject to the limitations of Subsection 2.1(c) and Subsection 2.3. 

  
 4 

 (c) Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a
registration pursuant to this Subsection 2.1 a certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Company’s Board of Directors it would be materially detrimental to the Company
and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially interfere
with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as
confidential; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking action with respect to such filing, and any time periods with respect
to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more than one hundred twenty (120) days after the request of the Initiating Holders is given; provided, however, that the Company may not invoke this
right more than once in any twelve (12) month period. 
 (d) The Company shall not be obligated to effect, or to take any action to
effect, any registration pursuant to Subsection 2.1(a), (i) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty
(180) days after the effective date of, a Company-initiated registration, provided, that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (ii) with
respect to a registration initiated by the Series A Holders, after the Company has effected one registration pursuant to Subsection 2.1(a) at the request of the Series A Holders; (iii) with respect to a registration initiated by the
Series B Holders, after the Company has effected two registrations pursuant to Subsection 2.1(a) at the request of the Series B Holders; (iv) with respect to a registration initiated by the holders of Founder Shares, after the
Company has effected one (1) registration pursuant to Section 2.1(a); or (v) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3 or Form F-3 pursuant
to a request made pursuant to Subsection 2.1(a), The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1(a) (i) during the period that is thirty (30) days
before the Company’s good faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration, provided, that the Company is actively employing in good faith
commercially reasonable efforts to cause such registration statement to become effective; or (ii) if the Company has effected two registrations pursuant to Subsection 2.1(a) within the twelve (12) month period immediately preceding
the date of such request. A registration shall not be counted as “effected” for purposes of this Subsection 2.1(d) until such time as the applicable registration statement has been declared effective by the SEC; provided,
however, that if a registration is withdrawn by the Initiating Holders, such withdrawn registration shall be counted as “effected” for purposes of this Section 2.1(d) unless such Initiating Holders pay to the Company an
amount equal to the actual expenses reasonably incurred by the Company prior to the date of such withdrawal solely with respect to the registration of Registrable Shares held by such Initiating Holders. 

  
 5 

 2.2 Company Registration. If at any time after one hundred and eighty (180) days
after the effective date of the registration statement for IPO the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than the Holders) any of its A Ordinary Shares under the
Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each
Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the provisions of Subsection 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested
to be included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to
include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance with Subsection 2.6. 

2.3 Underwriting Requirements. 

(a) If, pursuant to Subsection 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by their request by
means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Subsection 2.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will be selected by the Company and
shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s
participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with
the Company as provided in Subsection 2.4(e)) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this Subsection 2.3, if the managing
underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would
be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated as follows (x) 50% of the aggregate number of Registrable Shares to be included in the underwriting shall be
allocated to the Preferred Holders in proportion (as nearly as practicable) to the number of Registrable Securities owned by each such Holder proposed to be included in such offering, and (y) after giving effect to the immediately preceding
clause (x), the balance of Registrable Shares to be included in the underwriting shall be allocated to all Holders in proportion (as nearly as practicable) to the number of Registrable Securities owned by each such Holder proposed to be included in
such offering; provided, however, that the number of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from any such underwriting. No
underwriting agreement (or other agreement in connection with a proposed sale of the Registrable Securities) shall require any Holder of Registrable Securities to make any representations or warranties to or agreements with the Company or the
underwriters other than representations, warranties or agreements regarding such Holder, the ownership of the Holder’s Registrable Securities and such Holder’s intended method or methods of disposition and any

  
 6 

 
other representation required by law or to furnish any indemnity to any Person which is broader than the indemnity furnished by such Holder hereunder. To facilitate the allocation of shares in
accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 100 shares. 

(b) In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Subsection
2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company, its underwriters and the Holders
of a majority of the then-outstanding Registrable Securities (subject to the penultimate sentence of Section 2.3(a)), and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success
of the offering by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the
underwriters in their sole discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the
underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such
offering, then the Registrable Securities that are included in such offering shall be allocated in accordance with Section 2.3(a). Notwithstanding the foregoing, in no event shall the number of Registrable Securities included in the
offering be reduced unless all other securities (other than securities to be sold by the Company and any securities with registration rights on a pro rata basis with the Registrable Securities) are first entirely excluded from the offering. For
purposes of the provision in this Subsection 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members, stockholders, and
Affiliates of such Holder, or the estates and Priviliged Relation of any such partners, retired partners, members, and retired members and any Family Trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single
“selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as defined in
this sentence. 
 2.4 Obligations of the Company. Whenever required under this Section 2 to effect the registration of
any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare and file with the SEC a registration
statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable Securities registered
thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that such
one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of A Ordinary Shares (or other securities) of the Company, from selling any securities included
in such registration; 

  
 7 

 (b) prepare and file with the SEC such amendments and supplements to such registration
statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement; 

(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any
such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the underwriter(s) of such offering; 
 (f) use its commercially reasonable efforts to cause all such Registrable
Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; 

(g) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration; 
 (h) promptly make available
for inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling
Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s directors, employees, and independent accountants to supply all information reasonably requested by any such seller,
underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(i) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been
declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 
 (j) after such
registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or supplement such registration statement or prospectus. 

  
 8 

 In addition, the Company shall ensure that, at all times after any registration statement
covering a public offering of securities of the Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s directors may implement a trading program under Rule 10b5-1 of the
Exchange Act 
 2.5 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action
pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method
of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities. 
 2.6
Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or qualifications pursuant to this Section 2, including all registration, filing, and qualification fees;
printers’ and accounting fees; fees and disbursements of counsel for the Company; and the reasonable fees and disbursements, not to exceed $50,000 of one counsel for the selling Holders (“Selling Holder Counsel”), shall be
borne and paid by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Subsection 2.1 if the registration request is subsequently withdrawn at
the request of the Holders of a majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn
registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Subsection 2.1(a) or Subsection 2.1(b), as the case may be. All Selling Expenses relating to
Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on their behalf. 

2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. If any Registrable Securities are included in a registration statement under this Section 2: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, members, officers,
directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if any, who controls such Holder or underwriter within the
meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person any legal or other expenses reasonably incurred thereby in
connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Subsection 2.8(a) shall not apply to
amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, 

  
 9 

 
which consent shall not be unreasonably withheld, nor shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon
and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person, or other aforementioned Person for use in connection with such registration. 

(b) To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of
its directors, each of its employees who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in
the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against any Damages, in each case only to the extent that such Damages arise out of or are
based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder for use in connection with such registration; and each such selling Holder will pay to the Company and
each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however,
that the indemnity agreement contained in this Subsection 2.8(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be
unreasonably withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity or contribution under Subsections 2.8(b) and 2.8(d) exceed the proceeds from the offering
received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder. 

(c) Promptly after receipt by an indemnified party under this Subsection 2.8 of notice of the commencement of any action (including
any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Subsection 2.8, give the indemnifying
party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to which notice has been
given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual
or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the commencement of any such action
shall relieve such indemnifying party of any liability to the indemnified party under this Subsection 2.8, to the extent that such failure materially prejudices the indemnifying party’s ability to defend such action. The failure to give
notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Subsection 2.8. 

  
 10 

 (d) To provide for just and equitable contribution to joint liability under the Securities Act
in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Subsection 2.8 but it is judicially determined (by the entry of a final judgment or decree by a
court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Subsection 2.8 provides for
indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Subsection 2.8, then, and in each such case, such panics will
contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the
indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to
information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided, however, that, in
any such case, (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement (except in the case of
fraud or willful misconduct by such Holder), and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(0 of the Securities Act) will be entitled to contribution from any Person who was not guilty of
such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Subsection 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Subsection
2.8(b), exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. 

(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the
obligations of the Company and Holders under this Subsection 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall survive the termination of this
Agreement. 
 2.9 Reports Under Exchange Act. With a view to making available to the Holders the benefits of SEC Rule 144 and any
other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3 or Form F-3, the Company shall: 

(a) make and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all times
after the effective date of the registration statement filed by the Company for the IPO; 

  
 11 

 (b) use commercially reasonable efforts to file with the SEC in a timely manner all reports and
other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and 

(c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a
written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the IPO), the Securities
Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 or Form F-3 (at any time after the Company so
qualifies); (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company; and (iii) such other information as may be reasonably requested in availing any Holder of
any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form S-3 or Form F-3 (at
any time after the Company so qualifies to use either such form). 
 2.10 Limitations on Subsequent Registration Rights. Subject to
the terms of the SSA, from and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders of a majority of the Registrable Securities then-outstanding, enter into any agreement with any holder or
prospective holder of any securities of the Company that would provide to such holder the right to include securities in any registration on other than either a pro rata basis with respect to the Registrable Securities or on a subordinate basis
after all Holders have had the opportunity to include in the registration and offering all shares of Registrable Securities that they wish to so include. 

2.11 “Market Stand-off’ Agreement. Each Holder hereby agrees that it will not, without the prior written consent of the
managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company of A Ordinary Shares or any other equity securities under the Securities Act on a registration statement on Form S-l,
Form F-1, Form S-3 or Form F-3, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days in the case of the IPO, or such other period as may be requested by the
Company or an underwriter to accommodate regulatory restrictions on (1) the publication or other distribution of research reports and (2) analyst recommendations and opinions, including, but not limited to, the restrictions contained in
FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), or (y) ninety (90) days in the case of any registration other than the IPO, or such other period as may be requested by the Company or an
underwriter to accommodate regulatory restrictions on (1) the publication or other distribution of research reports and (2) analyst recommendations and opinions, including, but not limited to, the restrictions contained in FINRA Rule
2711(f)(4) or NYSE Rule 472(f)(4), or any successor 

  
 12 

 
provisions or amendments thereto), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right,
or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any A Ordinary Shares or any securities convertible into or exercisable or exchangeable (directly or indirectly) for A Ordinary Shares (whether such shares or any
such securities are then owned by the Holder or are thereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether
any such transaction described in clause (i) or (ii) above is to be settled by delivery of A Ordinary Shares or other securities, in cash, or otherwise. The foregoing provisions of this Subsection 2.11 shall not apply
to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall be applicable to the Holders only if all directors are subject to the same restrictions. The underwriters in connection with such registration are intended
third-party beneficiaries of this Subsection 2.11 and shall have the right, power, and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably
requested by the underwriters in connection with such registration that are consistent with this Subsection 2.11 or that are necessary to give further effect thereto. 

2.12 Restrictions on Transfer. 

The Series B Preferred Shares, the Series A Preferred Shares, the Founder Shares and the Registrable Securities shall not be sold, pledged, or
otherwise transferred except in accordance with the Articles. 
 Each certificate or instrument representing (i) the Series B Preferred
Shares, the Series A Preferred Shares or the Founder Shares, (ii) the Registrable Securities, and (iii) any other securities issued in respect of the securities referenced in clauses (i) and (ii), upon any stock split,
stock dividend, recapitalization, merger, consolidation, or similar event, shall be stamped or otherwise imprinted with a legend substantially in the following form: 

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933. SUCH SHARES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND
THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 The Holders consent to the Company making a notation in
its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Subsection 2.12. 

  
 13 

 2.13 Termination of Registration Rights. The right of any Holder to request registration
or inclusion of Registrable Securities in any registration pursuant to Subsection 2.1 or Subsection 2.2 shall terminate upon the earliest to occur of: 

(a) the closing of a Disposal or Share Sale, as such terms are defined in the Articles; 

(b) such time as Rule 144 or another similar exemption under the Securities Act is available for the sale of all of such Holder’s shares
without limitation during a three-month period without registration; and 
 (c) the seven (7) year anniversary of the IPO. 

2.14 Required Registration. The parties acknowledge that the definition of IPO in this Agreement is inconsistent with the definition of
‘Listing’ in the Articles and that equivalent rights are not relevant in the context of a public offering undertaken outside the United States. Notwithstanding such conflict, the parties hereto agree if the Company pursues an IPO (within
the meaning of the definition in this Agreement) that the provisions in Sections 2 and 3 shall apply. 
 3.
Miscellaneous. 
 3.1 Successors and Assigns. The rights under this Agreement may be assigned (but only with all related
obligations) by a Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Priviliged Relation or Family Trust for the benefit of an individual Holder or one or more of such
Holder’s Priviliged Relations; or (iii) after such transfer, holds at least ten percent (10%) of the aggregate number of shares of all Registrable Securities held by all Holders (or such lesser number of shares if such Holder is
transferring all of such Holder’s Registrable Securities); provided, however, that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and
the Registrable Securities with respect to which such rights are being transferred; and (y) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement,
including the provisions of Subsection 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder;
(2) who is a Holder’s Priviliged Relation; or (3) that is a Family Trust for the benefit of an individual Holder or such Holder’s Priviliged Relation shall be aggregated together and with those of the transferring Holder;
provided further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking any action under this Agreement. The terms
and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the
parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein. 

  
 14 

 3.2 Governing Law. This Agreement shall be governed by the internal law of the State of
New York. 
 3.3 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and
validly delivered and be valid and effective for all purposes. 
 3.4 Titles and Subtitles. The titles and subtitles used in this
Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. 
 3.5 Notices. All
notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (i) personal delivery to the party to be notified; (ii) when sent,
if sent by electronic mail or facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by
registered or certified mail (air mail if to or from outside the United States), return receipt requested, postage prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier,
freight prepaid, specifying next-day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their addresses as set forth on Schedule A hereto, or to the principal office of the Company
and to the attention of the Chief Executive Officer, in the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written notice given in accordance with this Subsection 3.5. If notice is
given to the Company, copies (which shall not constitute notice) shall also be sent to Howard Palmer, Taylor Wessing LLP, 5 New Street Square, London EC4A 3TW and Goodwin Procter LLP, Exchange Place, Boston, MA 02109, Attention: Mark J. Macenka, and
if notice is given to Investors, a copy shall also be given to Goodwin Procter LLP, The New York Times Building, 620 Eighth Avenue, New York, NY 10018, Attention: Han Nissan. 

3.6 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders of a majority of the Series B Preferred Shares then outstanding (voting as a separate class), a
majority of the Series A Preferred Shares then outstanding (voting as a separate class) and a majority of the Founder Shares then outstanding (voting as a separate class); provided that any provision hereof may be waived by any waiving party
on such party’s own behalf, without the consent of any other party. Notwithstanding the foregoing, this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the
written consent of such Investor, unless such amendment, termination, or waiver applies to all Investors in the same fashion. The Company shall give prompt notice of any amendment or termination hereof or waiver hereunder to any party hereto that
did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this Subsection 3.6 shall be binding on all parties hereto, regardless of whether any such party has
consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision. 

  
 15 

 3.7 Severability. In case any one or more of the provisions contained in this Agreement is
for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be
reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 
 3.8 Aggregation of
Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as
among themselves in any manner they deem appropriate. 
 3.9 Entire Agreement. This Agreement (including any Schedules and Exhibits
hereto) constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly
canceled. 
 3.10 Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the
state courts of State of New York and to the jurisdiction of the United States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree
not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of New York or the United States District Court for the Southern District of New York, and (c) hereby waive, and agree
not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. 

WAIVER OF JURY TRIAL: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS
AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT
MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS, THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO
AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL
RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. 

  
 16 

 3.11 Delays or Omissions. No delay or omission to exercise any right, power, or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or
acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All
remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 [Remainder
of Page Intentionally Left Blank] 

  
 17 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
		 	MIMECAST LIMITED
		
	By:	 	 /s/ Peter Campbell

	Name:	 	 Peter Campbell

	Title:	 	 Secretary & Director

			
	INSIGHT VENTURE PARTNERS VII, L.P.
		
	By:	 	Insight Venture Associates VII, L.P. its General Partner
	By:	 	Insight Venture Associates VII, Ltd., its General Partner
		
	By:	 	 /s/ illegible

	Name:	 	
	Title:	 	
	
	INSIGHT VENTURE PARTNERS (CAYMAN) VII, L.P.
		
	By:	 	Insight Venture Associates VII, L.P. its General Partner
	By:	 	Insight Venture Associates VII, Ltd., its General Partner
		
	By:	 	 /s/ illegible

	Name:	 	
	Title:	 	
	
	INSIGHT VENTURE PARTNERS VII (CO-INVESTORS), L.P.
		
	By:	 	Insight Venture Associates VII, L.P. its General Partner
	By:	 	Insight Venture Associates VII, Ltd., its General Partner
		
	By:	 	 /s/ illegible

	Name:	 	
	Title:	 	
	
	INSIGHT VENTURE PARTNERS (DELAWARE) VII, L.P.
		
	By:	 	Insight Venture Associates VII, L.P. its General Partner
	By:	 	Insight Venture Associates VII, Ltd., its General Partner
		
	By:	 	 /s/ illegible

	Name:	 	
	Title:	 	

			
	INSIGHT VENTURE PARTNERS CO INVESTMENT FUND II, L.P.
		
	By:	 	Insight Venture Associates Coinvestment II, L.P. its General Partner
	By:	 	Insight Holding Group, LLC, its General Partner
		
	By:	 	 /s/ illegible

	Name:	 	
	Title:	 	

 PETER BAUER 
  

							
	SIGNED as a DEED and DELIVERED	 	)	 	/s/ Peter Bauer
	by PETER BAUER in the	 	)	 	  

	presence of:	 	)	 	
				
	witness signature	 	 /s/ Mark Bilbe
	 		 	
				
	witness name	 	 Mark Bilbe
	 		 	
				
	witness occupation	 	 General Manager, Mimecast USA
	 		 	

 NEIL MURRAY 
  

							
	SIGNED as a DEED and DELIVERED	 	)	 	/s/ Neil Murray
	by NEIL MURRAY in the	 	)	 	  

	presence of:	 	)	 	
				
	witness signature	 	 /s/ Clive Thomas
	 		 	
				
	witness name	 	 Clive Thomas
	 		 	
				
	witness occupation	 	 solicitor
	 		 	

 BUTTER WORTH TRUST 
  

							
	EXECUTED and DELIVERED as a DEED	 	)	 	/s/ Graeme Harker
	By BUTTERWORTH TRUST	 	)	 	Trustee
		 		 	)	 	
		 		 	)	 	
		 		 	)	 	
		 		 	)	 	Trustee

 INDEX VENTURES V (JERSEY), L.P. 
  

							
	 EXECUTED and DELIVERED as a DEED
 by INDEX
VENTURES V (JERSEY), L.P.
 By: its Managing General Partner:

Index Venture Associates V Limited
	 		 		 	 )
 ) /s/ Paul Willing

)
 )

) Director / Authorised Signatory

 INDEX VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY), L.P. 

 

							
	 EXECUTED and DELIVERED as a DEED
 by INDEX
VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY), L.P.
 By: its Managing General Partner:

Index Venture Associates V Limited
	 		 		 	 )
 ) /s/ Paul Willing

)
 )

)
 ) Director / Authorised Signatory

 YUCCA PARTNERS LP JERSEY BRANCH 
  

							
	 EXECUTED and DELIVERED as a DEED
 by YUCCA
PARTNERS LP JERSEY
 BRANCH
 By: Ogier Employee Benefit

Services Limited in its capacity as administrator
 of the Index
Co-Investment Scheme as
 Authorised Signatory of Yucca Partners LP
	 		 		 	 )
 ) /s/ illegible

)
 )

)
 ) Authorised Signatory

- Ogier Employee Benefit Services Limited

 DAWN ENTERPRISE CAPITAL FUND LP 
  

							
	 EXECUTED and DELIVERED as a DEED
 by DAWN
ENTERPRISE CAPITAL
 FUND LP acting by its general partner
 DAWN
CAPITAL LLP
	 		 		 	 ) /s/ illegible
 ) Authorised Signatory

)
 )

) /s/ Norman Fiore
 ) Authorised Signatory

 DAWN MIMECAST (II) HOLDINGS LIMITED 
  

							
	 EXECUTED and DELIVERED as a DEED
 by DAWN
MIMECAST (II)
 HOLDINGS LIMITED
	 		 		 	 ) /s/ Vincent McCartney
 ) Director

)
 )

) /s/ Karen Bell
 ) Director/Secretary

 SCHEDULE A 

Investors 
 Peter Bauer 

78 Main Street 
 Southborough, MA 01772 

Neil Murray 
 Stoke Gap House 

Ashton Road 
 Stoke Bruerne 

Northamptonshire 
 NN12 7AM 

Butterworth Trust 
 Rock House 

Sark 
 GY9 0SD 

Dawn Enterprise Capital Fund LP 
 C/o Dawn Capital LLP 

14 Buckingham Street 
 London 

WC2N 6DF 
 Dawn Mimecast (II) Holdings Limited 

PO Box 3175 
 Road Town 

Torlola 
 British Virgin Islands 

Index Ventures V (Jersey), L.P., 
 Index Ventures Associates V
Limited 
 Whiteley Chambers 
 Don Street 

St. Helier 
 Jersey 

JE4 9WG 
 Channel Islands 

 Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. 

Index Ventures Associates V Limited 
 Whiteley Chambers 

Don Street 
 St. Helier 

Jersey 
 JE4 9WG 

Channel Islands 
 Yucca Partners L.P. Jersey Branch 

C/o Ogier Employee Benefit Services Limited 
 Whiteley Chambers

 Don Street 
 St. Helier 

Jersey 
 JE4 9WG 

Channel Islands 
 Insight Venture Partners VII, L.P. 

680 Fifth Avenue 
 New York, NY 10019 

Insight Venture Partners (Cayman) VII, L.P. 
 680 Fifth Avenue

 New York, NY 10019 
 Insight Venture Partners VII
(Co-Investors), L.P. 
 680 Fifth Avenue 
 New York, NY 10019

 Insight Venture Partners (Delaware) VII, L.P. 
 680 Fifth
Avenue 
 New York, NY 10019 
 Insight Venture Partners
Coinvestment Fund II, L.P. 
 680 Fifth Avenue 
 New York, NY
10019

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]